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Abstract
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Early-Detection of Diabetic Foot Ulceration using Thermal Images
by Benjamin Jan Paul Kluwe
The purpose of this document is to provide an overview of the author's research into
the early detection of diabetic foot ulceration using infrared imaging. This project
may contribute to better treatment and potentially help to avoid a signicant amount
of amputations and deaths.
An experimental infrared system was developed and successfully tested within the
framework of a clinical trial on 109 healthy volunteers and 112 diabetic patients
at 3 collaborating clinical centres with the aim of providing information on what
dierentiates a 'normal', healthy foot from a diabetic foot.
This information was then used to develop a novel methodology for acquiring and
analysing thermal data with the aim of identifying suitable predictors for ulceration.
Results indicate that the proposed classiers may be used to forecast diabetic foot
ulcers provided assessment intervals are short, ideally daily.
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Diabetes aects 3.6 million people in the UK (5.5 % of the population). Since 1996
diabetes prevalence has doubled to the current number and over the last 3 years it
has risen by approximately 250,000 cases per year. Accordingly, the cost for diabetic
care is the highest source of spending for the NHS, at 10 billion pounds per year,
equating 10 % of the NHS budget [1]. Diabetic foot ulcers are a common complication
in diabetic patients. It is estimated that 1 %-1.4 % of all diabetics will develop a foot
ulcer each year and approximately 15 % of diabetics will develop an ulcer within
their lifetime [2, 3]. A Diabetic Foot Ulcer (DFU) will often lead to infection and, if
not treated rapidly, gangrene and amputation. As a consequence 15 %-27 % of DFUs
lead to the surgical removal of bone[4].
Diabetic foot care has gradually improved over the years but the predominant prob-
lem remains the detection of the onset of diabetic foot ulceration at the earliest
point in time - if possible well before the actual ulcer manifests itself. At the mo-
ment treatment can only be started when the ulcer is close to developing or already
has developed, which is often too late and if the treatment does not work, the foot
or parts of the foot need to be amputated. This will not only lead to a severe reduc-
tion in the quality of the patient's life but additionally, the likelihood of the patient
deceasing within 5 years after an amputation is up to 75 % [5]. Some studies even
claim a mortality rate of 35 % to 65 % within the rst three years after amputation
[2].
An ulcer tends to develop from pressure zones underneath the foot when a person
steps unevenly due to loss of sensation in their feet (neuropathy) or restricted blood
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ow (angiopathy). After a period of time, the pressure zone develops into an irrita-
tion under the skin. The irritated area then gradually extends towards the surface
where it eventually breaks through the skin. This process is not only painful for non-
neuropathic patients but also foreshadows the aforementioned complications. The
ability to detect a developing foot ulcer is currently limited by two factors:
1. Feet are visually inspected by podiatrists for redness and abnormalities. Ulcers
however develop under the skin, therefore visual inspection may not provide
an accurate diagnosis.
2. Feet are inspected annually for low risk patients according to NICE guidelines
[6, see section 1.3.11]. A patient is classied into low, moderate, high or very
high risk of developing an ulcer after each assessment and the next visit is
planned accordingly. An ulcer that develops between visits will therefore be
missed. This chance is greatest in low and moderate risk patients.
This work is attempting to address the above problem by exploiting the fact that a
developing foot ulcer causes a change in blood ow to the aected area of the foot
as the body mounts an inammatory response to the causal irritations. These are
usually mechanical: shear, friction or foreign bodies in footwear but also prolonged
weight bearing on bony prominences. Other factors include excessive heat exposure
(e.g. sand on a hot beach), cold and callus formation resulting in pressure and broken
skin or some sort of traumatic injury. This in turn causes skin temperature to rise
[7]. An early detection of the onset of foot ulceration could therefore be possible
by measurement of skin temperature using thermochromic liquid crystal sheets or
infrared cameras. The latter is preferred as it is a non-contact method.
1.2 Aim
The aim of this research project is to develop, implement and evaluate a method for
the early detection of developing foot ulceration by using infrared imaging techniques.
1.3 Hypothesis
Diabetic foot ulcers can be predicted by infrared imaging due to an increase in
bloodow under the skin caused by an inammatory response.
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1.4 Ojectives
In order to achieve the above aim the project has to meet the following objectives:
1. Research into the underlying physical principles of infrared imaging, detector
technologies and their respective spatial and thermal resolutions, and error
sources associated with both technology and usage in clinical practice.
2. Development of hardware and software for a device capable of addressing the
aim in a clinically feasible manner, this means technically, but not method-
ologically, a medical device.
3. Implementation of the device and provision to the 3 clinical centres associated
with this project (see section 1.5).
4. Implementation of a website capable of mass manual image object outlining.
5. Analysis of the data collected by the clinical centres with the aim of:
 Establishing and verifying a methodology for data extraction and group-
ing
 Conrming/rejecting the currently accepted 2.2 ◦C temperature asymme-
try threshold [8]
 Finding an improved method over the 2.2 ◦C temperature asymmetry
threshold
1.5 Project Framework
The work described in this dissertation was embedded in a ¿1.2 million National
Institute for Health Research (NIHR) funded Invention for Innovation (i4i) project.
The project was lead by the National Physical Laboratory (NPL). The collaborating
partner organisations were 3 UK Hospitals under the clinical lead of King's College
London. Further participants were Photometrix Imaging Ltd (instrument design)
and the University of South Wales where the author is a PhD student. The project
timeline was as follows:
1. Writing an NIHR i4i grant application (2013/14)
2. In parallel: (Mid 2014)
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(a) Development of the clinical protocol
(b) Technical R&D into an infrared imaging capable device
3. Ethics approval of the clinical protocol (End 2014)
4. MHRA approval to use the device as a medical device (2014/15)
5. Trial 1 on 109 healthy volunteers (2015/16)
6. Trial 2 on 112 diabetic patients with an ulceration history (2016/17)
7. Development of a second generation device (2017/18)
The author contributed to parts 2 (b), 5, 6 and 7.
Chapter 2
Background Research
In order to meet the objectives of this work this chapter is investigating:
 the motivation and justication for this work and possible approaches (section
2.1)
 human foot physiology (section 2.2)
 the underlying physics of IR imaging (section 2.3)
 potential hardware platforms that could be employed (section 2.4)
 a number of software techniques/algorithms that are useful in the context of
this work (section 2.5)
2.1 Diabetic Foot Ulceration
2.1.1 Detection
The current method of detecting foot ulcers is visual inspection. However, due to
the nature of how an ulcer develops, it is very dicult to visually detect or predict
its formation. The work of van Netten et al., who are key contributors in this
eld, suggest an alternative method using infrared thermography by measuring the
dierence in temperature at contralateral spots on the feet of diabetics. In their
study, they conrm the 2.2 ◦C threshold that was previously established as clinically
signicant by Armstrong and Lavery [9, 10] and achieved a sensitivity of 76 % and
5
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specicity of 40 % [8, 11]. The papers used patients cohorts of size 85, 173, 15 and
54, respectively.
More recently a study by Frykberg quotes a sensitivity of 90 % but a specicity of only
43 % for an at least 2-day consecutive temperature threshold of 2.75 ◦C and a mean
lead time of 37 days. In the study data was collected from a "smart temperature
mat" for home use from 132 patients where the device was used 5.5± 1.2 times per
week. False positives were identied when no ulcer occurred at most 2 months after
the threshold was exceeded [12].
These studies provide the foundation of the hypothesis in 1.3 and justication for
the work described in this thesis.
2.2 Physiological Factors Inuencing Skin Temperature
2.2.1 Mass and Surface Area
The mass and surface area of a foot are proportional to the temperature that it can
maintain. The characteristic is measured in m2kg−1 and is a good indication for how
much heat is being radiated by a foot at a given point in time. For an average male,
the surface area to mass ratio is about 0.069 and for the average female it is about
0.084. These values are approximately three times larger than the surface area to
mass ratio of the whole body. This demonstrates that feet act as radiators that can
be turned on and o by regulating blood ow and their thermal properties need to
be taken into account in measurements over time [13].
2.2.2 Blood Flow
Blood ow beneath the skin has a dramatic eect on the temperature of the foot.
Blood ow is measured as the amount of blood that reaches each 100 mL of cellular
tissue per minute (mLblood 100 mL
−1
cell tissue min
−1) of the total limb volume over time.
As mean body temperature and local skin temperature rise, the blood ow increases
up to 14 mLblood 100 mL
−1
cell tissue min
−1, but drops down to a minimum of about
0.8 mLblood 100 mL
−1
cell tissue min
−1 when both mean and local skin temperature drop,
which is the minimum amount of blood ow to sustain cellular tissue [13].
In the context of this work it is anticipated that visible foot ulceration is preceded
by an inammatory reaction of the aected tissue [9] with an associated increase in
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blood ow. A thermal camera should be able to detect the onset of such ulceration
by observing a hot spot on those parts of skin that are covering the damaged tissue.
It may be necessary to apply a cold stimulus or provocation to the foot (e.g. fan
cooling) in order to visualise such a hot spot: normal unaected tissue will react
by closing down capillaries in order to prevent heat loss and thus cool down while
the inammatory tissue will remain well perfused and thus appear hotter than its
surrounding tissue [14].
2.3 The Physics of Infrared Imaging
The physics behind Infrared Imaging involve multiple aspects that have to be taken
into account in order to produce a radiometric image of sucient quality. It is
therefore important to understand how an image is created at the physical layer to
correctly interpret the temperature output at a later stage.
2.3.1 Radiation
Radiation is perceived in the form of electromagnetic (EM) waves traversing space.
An EM wave consists of two separate parts, the electric eld and the magnetic eld,
each oscillating in phase at 90° towards to each other. Every EM wave has a specic
wavelength and amplitude. The wavelength is a measurement of the wave from peak
to peak (or trough to trough) and the amplitude is the min/max values of the wave.
The focus of this study is infrared radiation, which is dened as EM waves with a
wavelength between 1 µm and 10 µm [15, chapter 3].
2.3.2 Infrared Spectrum
The infrared spectrum is split into three dierent sections: short-wave infrared radia-
tion (SWIR), mid-wave infrared radiation (MWIR) and long-wave infrared radiation
(LWIR), which can be dened at 1-3 µm, 3-5 µm and 5-10 µm, respectively.
The wavelength with the peak spectral radiance of a black body at a specic tem-
perature is calculated using Wien's law. It is calculated using
λmax = b/T (2.1)
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where T is the absolute temperature in Kelvin (K) and b is Wien's displacement
constant. Using the human body as a reference point at about 30-35 ◦C (303.15-
308.15 K), the peak emission wavelength is between 9.4 and 9.6 µm, which falls into
the LWIR spectrum. Even though SWIR and MWIR sensors would provide a greater
contrast based on Planck's law in terms of wavelength, the signicantly reduced
amount of incident spectral radiation would increase the measurement error. For
this reason LWIR sensors a better t than SWIR and MWIR sensors for this project.
The full spectral radiance vs. wavelength graph is given by Planck's law [15, chapter
5].
2.3.3 Emissivity
The emissivity of an object is a measure of how eective infrared radiation is cast out
by the object. The emissivity of an object can range from 0 to 1, where 0 is an object
that does not emit infrared radiation at all, for example an ideal mirror, and 1 for an
object that perfectly emits radiation, a so called black body. It is measured by the
dierence in radiation from a blackbody reference source (calculated from Plancks
law) and the experimental value [15, chapter 5]. The object of interest in this study
is the human skin, which is a near-perfect blackbody source with an emissivity of
0.98 [15, chapter 2].
2.3.4 Detector Types and Materials
There are three types of detectors that can be used: photoconductive, photovoltaic
and thermal. The three types determine how the radiation is captured and passed
on to a readout chip. In photoconductive detectors, the radiation is converted into a
current through electron excitation. Similarly, photovoltaic detectors induce a volt-
age using a diode junction when radiation of the wavelength range for which they
are designed hits them. The wavelength that is captured by the detector depends
on the materials that are used. Thermal detectors use a dierent approach; they
convert the radiation into heat which then changes the electrical characteristics of
resistive elements. Some of the detector materials for infrared cameras include InSb
for 5 µm wavelength for MWIR, HgCdTe for 5 and 10 µm, AlGaAs (quantum well
infrared photo detector, QWIP) for 5 and 10 µm and uncooled bolometers for 10 µm
imaging. Each detector type, except for the bolometer, must be cooled to make the
detector function and reduce error sources such as the inherent resistance of elec-
trical components, which generate heat when current passes through them and to
Chapter 2 - Background Research 9
reduce electronic noise [15, chapter 3]. This means that photoconductive and photo-
voltaic detectors produce the most accurate results but are also far more expensive
to produce and maintain than bolometers. The cost aspect is also what makes the
use of photoconductive and photovoltaic detectors impractical for use in an everyday
hospital setting. The dierences are summarised in table 2.1.
Detector Type Captured wavelength band Cooling Method of data extraction
Photoconductive Narrow Must Current
Photovoltaic Narrow Must Voltage
Thermal Wide May Resistor voltage drop
Table 2.1: Comparison of detector types
2.3.5 Infrared Camera Characterisation
An infrared camera is typically characterised by its performance in terms of thermal-
and spatial-resolution. To measure the thermal resolution, the camera is subjected to
a uniform, large target where the input radiation is controlled. The root mean square
of the 3 dimensional noise (width, height and time, expressed in volts) is measured
and divided by the response of the System Intensity Transfer Function (SITF in
volts/K), giving the Noise Equivalent Temperature Dierence (NETD). The NETD
represents the temperature dierence which would produce a signal equal to the cam-
era's noise and is inversely proportional to the Signal-to-Noise Ratio (SNR). Current
infrared cameras have a NETD in the range of 20 to 100 mK. Spatial resolution on
the other hand is measured using the eld of view, distance to target and the amount
of pixels in both the vertical and horizontal directions [15, chapter 4]. Combining
all three parts gives a measurement in pixels mm−1, where the physical maximum
resolution is given by the Rayleigh criterion: sin θr =
λ
d . The amount of pixels of
an imager is physically xed to the sensor array, in the case of the Optris TIM-400
Imager (the IR camera used in this work), there are 382x288 pixels available. The
newer FLIR Lepton sensor (the IR camera used in the 2nd generation device outlined
in chapter 6) comes in two versions which has either 80x60 or 160x120 pixels. Al-
though both the NETD and spatial resolution might seem to be adequate indicators
of quality for an infrared camera, the accuracy of infrared sensors is also inuenced
by an initial oset after being turned on and a lasting bias which both need to be
corrected. According to manufacturers' marketing material for uncooled bolometer
sensors this is typically ±2 ◦C or ±2 %, whichever is greater. It is often unclear in
the manufacturers' datasheets against what reference the ±2 % is measured against,
e.g. 2 % of the temperature in K or temperature in Celsius (C).
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2.3.6 Error Sources
The main error sources of infrared radiation measurement are the detector's own
temperature and background radiation. Depending on the detector material and
type, the methods to reduce the sources of error are dierent. Some infrared cameras
are cooled to below temperatures of 80K to reduce the amount of infrared radiation
emitted from the detector itself [15, chapter 3]. Whether the camera is cooled or
uncooled, the background radiation is corrected with error correction formulas.
An infrared camera is characterised by its horizontal, vertical and temporal noise
attributes. These three attributes are used in the calibration step (error correction)
of the camera, which occurs in a pre-dened interval but can usually also be dened
by the user. This ensures that the image corresponds to the real world object being
imaged [15, chapters 4 and 5].
The choice of IR camera for this project was based on understanding their respec-
tive limitations and inaccuracies. For this project it was important to realise that a
bolometer camera is adequate enough to dierentiate usual skin temperature uctu-
ation from skin temperature abnormality. The reasoning for this choice is provided
in the following section 2.4.
2.4 Hardware
2.4.1 Infrared Cameras
Most of todays infrared cameras make use of uncooled bolometers, an array of nega-
tive temperature coecient (NTC) resistors that reduce their resistance when heated
by incoming infrared radiation. The cost of a uncooled bolometer camera has de-
creased dramatically over the last 20 years due to chip size reduction and smaller
pixel sizes. Currently, the price range for an infrared camera is within thousands
of dollars (US). From table 2.2, the price range in terms of dollar per pixel range
puts most infrared cameras at around 0.05-0.2 dollars per pixel. For comparison, a
Full HD webcamera (1920x1080 pixels) costs about 30 dollars which corresponds to
1.44× 10−5 dollars per pixel.
All of the cameras listed in table 2.2 are embedded devices and therefore include
unnecessary components such as a screen, which is reected in the cost of each
device. Alternatively, it is possible to use sensors with common interfaces such as
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USB or I2C such as the FLIR Lepton or Micro-Epsilons TIM infrared imagers. Table
2.3 shows a comparison between the two cameras.
Part# Brand Price (USD) Resolution (Pixels) Dollars per Pixel Thermal Sensitivity Accuracy
FLIRE4 FLIR 995.00 80 X 60 (4,800) 0.207 <.15C ±2 %
FLIRE5 FLIR 1,495.00 120 X 90 (10,800) 0.138 <.10C ±2 %
FLIRE40BX FLIR 3,995.00 160 X 120 (19,200) 0.208 <.045C -
FLIRE6 FLIR 2,495.00 160 X 120 (19,200) 0.130 <.06C ±2 %
FLIRE40 FLIR 3,995.00 160 X 120 (19,200) 0.208 <.07C ±2 %
TI20060HZ Fluke 6,299.95 200 X 150 (30,000) 0.210 <.08C ±2 %
TI30060HZ Fluke 6,999.95 240 X 180 (43,200) 0.162 <.05C ±2 %
FLIRE50 FLIR 5,995.00 240 X 180 (43,200) 0.139 <.05C ±2 %
FLIRE60 FLIR 7,995.00 320 X 240 (76,800) 0.104 <.045C ±2 %
TI40060HZ Fluke 8,495.00 320 X 240 (76,800) 0.111 <.05C ±2 %
FLIR440BX FLIR 11,750.00 320 X 240 (76,800) 0.153 <.05C ±2 %
FLIRT420 FLIR 8,750.00 320 X 240 (76,800) 0.114 <.05C ±2 %
FLIRT440 FLIR 11,750.00 320 X 240 (76,800) 0.153 <.05C ±2 %
FLIR420BX FLIR 8,750.00 320 X 240 (76,800) 0.114 <.05C ±2 %
FLIRE8 FLIR 3,995.00 320 X 240 (76,800) 0.052 <.06C ±2 %
FLIRT620 FLIR 20,950.00 640 X 480 (307,200) 0.068 <.05C ±2 %
Table 2.2: Comparison of FLIR and Fluke cameras [16] (market leaders at the
time of writing)
Part# Price (USD) Resolution (Pixels) Dollars per Pixel Thermal Sensitivity Accuracy
Micro-Epsilon TIM-400 7,573.80 382 X 288 (110,016) 0.069 <0.04/0.08C ±2 %
FLIR Lepton Version 2 (with Shutter) 170.00 80 X 60 (4,800) 0.036 <0.05C N/A
FLIR Lepton Version 3 (with Shutter) 240.00 160 X 120 (19,200) 0.013 <0.05C N/A
Table 2.3: Comparison of FLIR Lepton and Micro-Epsilon TIM-400 [17, 18]
For this project the Micro-Epsilon TIM-400 camera was selected as a preliminary
proof-of-concept device. It was the camera with the highest specication available
within the project budget at the time of purchase. While it is in all likelihood
over-specied in its performance parameters for the problem space its output can
be articially degraded using downsampling in order to simulate a lower specied
device. This allows the determination of minimum parameters that have to be met
by an IR imaging device in order to be used for a device to be used in clinical practice
(see chapter 6).
2.4.2 Infrared Camera Stability Tests
In the initial phases of the project, a test was carried out assessing the eect of
calibration on the infra-red camera to nd out how long it would take for the camera
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to stabilise. The experiment was designed to record the mean temperature of the
entire image for 20 minutes after turning it on. The camera was pointed at a uniform
temperature reference source at 30.0 ◦C, shown in gure 2.1a. A second independent
thermometer was used to verify the temperature of 30.0 ◦C, shown in gure 2.2
as the purple line. A calibration command was sent to the camera every minute.
The blue line shown in gure 2.2 represents the mean temperature of the entire
image after each calibration event and the red line shows the average temperature
before the calibration event. It shows that the camera becomes adequately stable
for measurements after about 10 minutes of being left on, as well as the necessity to
trigger the camera's internal calibration event just before an image gets taken. The
oset of about 1.5 ◦C is notable, but was most likely caused by the camera being
halfway inside the blackbody reference source and therefore the lens heating up to a
higher than normal temperature. In addition, the presented camera is the projects'
spare camera, i.e. that was characterised as the worst performer by the NPL among
the set of ve available cameras. The main outcome of this test is that the TIM-
400 cameras used in this study should be sent calibration event triggers at regular
intervals in order to prevent random oset uctuations in the output IR images.
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(a) TIM400 experiment setup
(b) TIM400 experiment setup
Figure 2.1: Experiment setup
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Figure 2.2: TIM-400 Characterisation Experiment Data
Purple line: LAND blackbody reference temperature as measured by PTR
Blue line: TIM-400 with calibration event on every 60 seconds (±2 ◦C as per data
sheet)
Red line: TIM-400 without calibration events
2.4.3 Computing Platforms
The platform on which the device is to be built has to full specic requirements.
It needs to be small and powerful enough to t into a mobile casing, allow real-time
video editing (xor rasterisation and alpha blending) in addition to fast User Interface
(UI) response times and the possibility to handle two visible light cameras for 3D
stereo imaging. This would allow for automatic detection and outlining of the foot
as well as merging multiple individual IR images into a single 3D representation.
It would also allow the correction of non-lambertian radiation power where the ori-
entation of the foot is not orthogonal to the camera, typically at the edges of the
foot. The software written for the device (see section 2.5) does not make use of a
Graphical Processing Unit (GPU) and thus it is not a necessary requirement but
is a nice-to-have for future developments. The following list is a summary of the
individual technical minimum requirements for the computing platform:
1. Hardware
(a) Two webcameras in order to facilitate 3D imaging
(b) One infrared camera
(c) Keyboard connection port for maintenance
(d) USB Stick with at least 1GB space for external IR image storage
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(e) Battery, rechargeable, 4 hours power
(f) At least one USB port for a USB hub or 4 USB ports for:
 Permanently: 1a and 1b
 Temporary: 1c and 1d
(g) Storage for at least 1 GB of image data
(h) Reasonably sized touchscreen for ease of use
2. Software
(a) 4 computation threads for 1a and 1b and real-time video editing
(b) 256 MB Memory for Linux and program overheads.
3. Low power consumption to prevent:
 Build-up of heat
 Fast battery exhaustion, 1e
4. Low EM emissions for CE marketing and medical device directive (MDD) reg-
ulatory compliance.
Some of the platforms that were available at the time were the Raspberry Pi 2, the
HummingBoard and the Odroid-U3. Each of these devices is small and provides
four to eight computing cores as well as a graphics processor (GPU) for fast image
processing. From the comparison in table 2.4, all three mentioned computing plat-
forms would be able to handle the requirements listed above. However, at the time
of planning and construction of the device, the Banana Pi, Roseapple Pi, Humming-
Board and Raspberry Pi 2/3 had not been developed yet, thus making the choice of
computing device straightforward: the Odroid-U3.
Name CPU Cores (Architecture) GPU Cores Memory USB Ports IO pins Cost (USD)
Raspberry Pi 1 A+ 1 (ARM11) 4 256MB 1 40 -
Raspberry Pi 1 B+ 1 (ARM11) 4 512MB 4 40 45
Raspberry Pi 2 4 (Cortex A7) 4 1GB 4 40 45
Raspberry Pi 3 4 (Cortex A7) 4 1GB 4 40 45
Odroid-U3 4 (Cortex A9) 4 2GB 3 - 69
HummingBoard 1/2/4 (FreeScale i.MX6) - up to 4GB 2/4 26/36 50-102
Roseapple Pi 4 (Cortex A9) 64 2GB 3 40 -
Banana Pi 4/8 2-64 up to 2GB 0-4 40 30-50
Table 2.4: Comparison of various small, mobile Computing Platforms [19, 20,
21, 22]
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2.5 Software
The software associated with this project is divided into 4 parts:
1. The device software
2. The analysis software for the users
3. The web-based analysis preparation software
4. The analysis software and scripts
The device software was written by the author for the purpose of visual and IR
image acquisition and transferring the images to a laptop provided to the clinical
users for this project. It provides facilities to enter basic patient information (trial
identier and date of birth) and semi-automatic organisation of data into folders.
It was expected that the users will use the USB transfer function in the software
regularly to copy the data from the device to a USB stick and further to a laptop.
The details of the device software are further explained in section 3.2.2
Once the data was transferred to the laptop, a separate piece of analysis software for
users, written by the authors' supervisor, was used to mark regions of interest (ROIs)
on the acquired images and export the data into the well known comma separated
values (CSV) format for further analysis.
The author's approach to the analysis is the usage of a standardised data set. This
means that all images are processed so that they show only the feet (removing any
background) and then, in a second stage, brought into a standard shape with identical
size, position and orientation. A pre-processing stage is therefore needed to segment
the foot or feet in each image from the background. Segmentation of the images is
a non-trivial task because the infra-red band may not contain adequate contrast to
the background for automated algorithms (for an example see gure 3.2a). In order
to aid segmentation with 3D data, two visual cameras were originally planned for
the system but could not be built in due to bandwidth limitations of the USB bus
of the Odroid-U3. Instead a single visual camera was used and the IR and visual
images were aligned manually. This was a labour intensive process but proved to be
sucient for the purpose of this study.
An alternative method is proposed by Vardasca et al. which allows semi-automatic
data collection by warping the original images into a standardised format [23]. How-
ever, the method can become time consuming when a large amount of control points
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need to be placed such as when curved outlines are involved. Instead, the author
proposes the use of cubic splines to interpolate control points and thus eectively
reduce the amount of control points that need to be placed.
Even though the amount of control points that needed to be placed was reduced,
there was still the need to place the points. For this purpose a web-based analysis
preparation software was created by the author that allows multiple people to
simultaneously place points on the data set and provides independent validation for
each image. The details of this piece of software are further explored in section 3.2.2.
After the outlines had been created on the images they could be made into a stan-
dardised data set from which temperatures could be automatically extracted. The
data was then able to be analysed by various classiers. The analysis software
and scripts are detailed in section 3.3.
2.5.1 Warping
The feet of people are thermally and geometrically very dierent from each other and
thus create technical problems when large amounts of image data are to be processed
automatically. The image data therefore has to be geometrically standardised before
it can be processed further. One method of doing this is called warping. Figure 2.3a
shows an example of placing control points and warping using a piece of software
written by the author. Figure 2.3b shows the resulting image, whose quality is lacking
for three reasons:
 The information was encoded using lossy compression, where some data is per-
manently lost when the le is saved. This can be xed by using the radiometric
data instead.
 Post image processing was applied to the image to ll patches of unknown data
created by the warping process.
 The temperature of the whole foot changes (see gure 2.3 and section 2.5.5)
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(a) Control point placement (numbers), original image size 382x288, here cropped
(b) Warped image from gure 2.3a, image size 764x576
Figure 2.3: Example of warping process using 29 control points (interpolated to
a total of 290)
As demonstrated in gure 2.3, the process of warping an image is altering parts of
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it into dierent shape(s) and size(s). There are two possible methods of performing
warping on an image; vector-based and pixel-based. Both methodologies are split
further into forward-mapping and backward-mapping algorithms. Forward-mapping
algorithms use the original image data and map it to new image data. Backward-
mapping does the exact opposite and works out the original pixel position in the
source image from the destination image position [24, 25].
Plenty of methods have been well explored in the computer animation industry due
to the practical application of altering 3D objects using specied control points.
Typically, an object is modelled in a rest pose and proceeds to be transformed using
techniques such as bone meshes. However, in a 2D environment, the rest pose can
be regarded as the original image. Most of the methods make use of barycentric
coordinates, which is a method of dening a shape based on edge points.
Barycentric coordinates can be calculated in a variety of ways, but they are all dened
by the reproduction property:
∑n
i=1wi(x)ci = x ∀x ∈ Ω, where c is a set of control
points, n is the amount of control points and w is a function of weights for each
x. There is a variety of methods available, such as mean value coordinates (MVC),
bounded biharmonic weights (BBW) and local barycentric coordinates (LBC) [26,
27, 28]. In this project, BBW was used because it provided the best t in terms
of calculation speed, locality and accuracy, this is explained in more detail in the
section 2.5.4.
2.5.2 Pixel Interpolation
After warping is complete, the image may be missing pixels due to the possibility of
enlarging parts of the image, thus creating black pixels. To compensate and allow for
data analysis, the black pixels need to be lled in a manner that seems coherent to
the human eye but at the same time does not alter the data by skewing the results.
Several techniques for approximations are available such as nearest neighbour, bi-
linear ltering and cubic interpolation.
The nearest neighbour approach uses each undened pixel and assigns the nearest
pixel's colour to it. The methodology uses a search algorithm for each pixel, making
it very fast. However, the quality of the resulting image is not satisfying in the
context of this work because it may override values from other neighbouring pixels,
and thus it might skew the data depending on the location of the pixels before and
after the transformation.
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On the other hand, ltering involves calculating the intermittent values between two
pixels based on the location of the resultant pixel, thus making a smooth transition
between the interpolated pixels. Bi-linear ltering takes into account the four ad-
jacent pixels and tri-linear ltering uses multiple progressively smaller, optimised,
sampling images (mipmaps) together with bi-linear ltering. Due to the fact that
the images being produced are in 2D, tri-linear ltering is not an option.
Bi-linear and bi-cubic ltering are very similar with regard to basing their interpola-
tion on the four surrounding pixels but calculate the interpolated pixels dierently.
Where bi-linear ltering uses linear tting, bi-cubic ltering uses cubic splines to
allow for a continuous gradient across the interpolated surface but in return takes
almost twice the time to compute.
Table 2.5 summarises the dierences between the aforementioned pixel interpolation
techniques. Although bi-cubic ltering produces visually more appealing images, bi-
linear ltering is the faster and simpler-to-implement interpolation method. It was
therefore chosen as the algorithm to perform pixel interpolation in the context of
this work.
Name Interpolation type Dimensionality skews data speed (seconds) suitable
Nearest neighbour threshold 2D/3D yes 0.0087 no
Bi-linear ltering linear 2D no 0.0120 yes
Tri-linear ltering linear 3D no - no
Bi-cubic ltering cubic spline 2D no 0.0222 yes
Table 2.5: Comparison of dierent Pixel Interpolation Techniques, speed is mea-
sured as the mean of 20 runs of up-scaling a 382x288 image to 764x576
2.5.3 Splines
The fundamental idea behind a spline is to create a smooth, curved boundary from
control points. The shape being dened by the control points is therefore non-linear
and employs curve tting to nd an optimal solution. This is particularly useful
for this project due to the shape of feet and the necessity for manual segmentation
arising from the lack of contrast in images. A non-linear approach to the problem
requires interpolation, a concept that has been known and used since the 1950s [29].
Today, several dierent methods of spline interpolation exist. However in this work
only methods that restrict the spline segments to pass through the control points are
suitable to ease the their placement. Table 2.6 shows some of the methods available
and their properties. For the purposes of this work, the cubic spline method was
found to be the most suitable.
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Name Passes through start and end point Passes through all control points
Bezier Curve Yes No
B-spline Yes No
Cubic Spline Yes Yes
Table 2.6: Comparison of dierent Spline Interpolation techniques [30, 31, 32]
2.5.4 Combining Cubic Splines with Barycentric Coordinates
A necessary step before any processing can begin is solving the problem that cubic
splines interpolation may create areas outside the polygon dened by the original
control points. This leads to negative barycentric values (see gure 2.4) and in turn
causes mapping vectors to reverse direction, eectively rendering the image warping
approach useless. To counter the problem, a solution was introduced by the author
to dene all interpolated points from the cubic spline algorithm as control points
(see section 7.2). In this approach, the polygon's area is extended to meet the cubic
spline. This solution however introduces another problem; how many control points
should be interpolated for each spline segment? Lastly, there was a choice between
the aforementioned methods of calculating the barycentric coordinates.
Generally, the choice of how many interpolated control points to use is a trade-o
between accuracy and computational complexity. As the number of interpolation
points increases, the boundary becomes smoother but in turn adds a dimension for
each added control point. However, the computational complexity is not a limiting
factor due to possibility of backward-mapping (see 2.5.1). The coordinates therefore
only need to be computed once for the destination image.
In order to assess the inuence of the number of interpolation points on the process 3
dierent barycentric calculation methods were tested with various amounts of points.
Each investigated calculation method was graphed as a map of the inuence of a given
selected point on the respective warping method. In gure 2.5 a higher inuence is
denoted by a higher coordinate value in relation to the selected point. The primary
constraint for choosing an appropriate method is that the inuence does not extend
to a region that is not within the line of sight of the selected point as it may cause
the region to move outside of the designated target polygon. Figure 2.5 shows the
outcome for 2 cases: one interpolation point and 10 interpolation points, where
one interpolation point signies the original control point set. While for the latter
calculations result in much smoother boundaries with each individual interpolated
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point inuencing a smaller area of the foot the higher amount of control points
causes the calculations to become eventually unstable as demonstrated by the "did
not compute" box for local barycentric coordinates.
Figure 2.4: Diagram showing where negative points would occur
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(a) Mean value coordinates
with 1 interpolated point
(b) Bounded Biharmonic
coordinates with 1 interpo-
lated point
(c) Local Barycentric
coordinates with 1 interpo-
lated point
(d) Mean value coordinates
with 10 interpolated points
(e) Bounded Biharmonic
coordinates with 10 interpo-
lated points
(f) Local Barycentric
coordinates with 10 interpo-
lated points
Figure 2.5: Comparison of dierent Barycentric Coordinate calculation methods
Colours indicate the inuence of the selected control point on the polygon when
warping
0 indicates no eect and 1 indicates full eect
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2.5.5 Validity of using Barycentric Coordinates
Although the method of combining barycentric coordinates with cubic splines works,
it remains to be shown that the method has an insignicant eect on the temper-
ature data once an image has gone through the warping process. This was tested
by comparing the mean and standard deviation of each of the 2270 plantar foot
infrared images in the second trial before and after warping. Figure 2.6 shows the
histograms of the temperature dierences of the mean between original and warped
images. Figure 2.6a shows the dierence for 0 interpolation points, gure 2.6b shows
the dierence for 1 interpolation point and gure 2.6c shows the dierence for 10
interpolation points. Figure 2.7 shows the histograms of the temperature dierences
of the standard deviation between original and warped images. Figure 2.7a shows
the dierence for 0 interpolation points, gure 2.7b shows the dierence for 1 interpo-
lation points and gure 2.7c shows the dierence for 9 interpolation points. For each
of these six gures, a t-test was carried out to identify any statistically signicant
changes in the data.
The t-test results outlined in 2.7 show that the p-values for both the mean and
standard deviation are between 0 and 0.001. These values allow the conclusion that
there is strong evidence that the data before and after the transformation dier
insignicantly. this is reinforced by the gures 2.6 and 2.7, which showcase the eect
of the warping process. Each mean histogram in gure 2.6 has few data points that
are close to -0.5 and 0.5 degrees dierence but overall most of the data falls within
the range of uncertainty of the infrared camera itself.
As already mentioned above, choosing the amount of interpolation points therefore
becomes a trade-o between smoothness of the spline and computational complexity.
The relationship between the amount of interpolation pixels and smoothness is 1n
whereas the computational complexity for warping is O(p∗n), where n is the number
of interpolation points and p the total number of points that need to be warped. The
smoothness of the curve is subject to qualitative assessment and therefore the number
of interpolation points that was deemed t for this task was set to 10.
Setting z-value (mean) p-value (mean) z-value (std. deviation) p-value (std. deviation)
0 points 35.54 4e-230 -40.37 2e-283
1 point 1.03 0.0079 -8.06 1e-15
9 points -11.7 0.0077 10.15 8e-24
Table 2.7: T-test statistic values for section 2.5.5




Figure 2.6: Histograms showing the dierence in mean temperature between
pre- and post-processing of each foot




Figure 2.7: Histograms showing the dierence in standard deviation temper-




The project's data collection was divided into two trials according to the project
plan devised by the i4i project consortium. The rst trial studied a control group
with healthy volunteers, followed by the second trial with diabetics. In each trial,
approximately 110 patients underwent an imaging process dened in the clinical




3. User Laptop Software
4. Device Software
The medical aspect of the project was assigned to the three hospitals involved in
this project (Pennine Acute Hospitals, Freeman Hospital Newcastle, Kings College
Hospital London), the Measurement Control aspect was directed by the National
Physical Laboratory, the User Laptop Software was allocated to the authors' super-
visor and the device software was assigned to the author. A copy of the protocols is
provided in appendix E. The main aspects of the clinicians check-list are summarised
below:
1. Check inclusion criteria:
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(a) Aged 18 or over
(b) Has intact feet
(c) Has palpable foot pulses
(d) Able to uently speak and understand English and be able to provide
meaningful written informed consent for the study
2. Check exclusion criteria:
(a) Has active foot ulceration and/or infection
(b) Has foot deformity which in the opinion of the Investigator, would interfere
with interpreting the results of the study
(c) Has any uncontrolled illness that, in the opinion of the Investigator, would
interfere with interpreting the results of the study
(d) Has an implantable electronic device
3. Record room humidity
4. Record room temperature (controlled as best possible to be between 22 and
24 ◦C).
5. Turn on the infrared camera device (starts warm-up and self-calibration).
6. Acclimatise the patient to room temperature for 10 minutes.
Each patient included in the study was assigned a trial identier and a group. The
identier consisted of three numbers followed by three letters, padded by underscores.
There were a total of three groups: A, B and C. Group A contained patients where
clinicians were blinded with respect to the thermal data (i.e. they could not see the
infrared image of the patients' feet, only the visual image), group B were not blinded
(clinicians could see both infrared and visual images) and patients in group C failed
the initial screening test and were thus not included in the trials.
The imaging device was programmed by the author to capture a software-dened
sequence of images, divided into 6 dierent views, plantar (both feet), dorsal (both
feet), left foot medial, right foot medial, left foot lateral and right foot lateral. Several
checks were built into the software to ensure that the sequence was recorded correctly:
 A time check was implemented to enforce that the device warming-up time
was observed. A further check guaranteed the correct time interval between
imaging sequence repetition specied in the clinical protocol.
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 After each sequence clinicians had to manually review each image and assess
if it included the whole foot, that it was at the right distance (see section
3.2.1 for implementation) and did not show any unwanted items or occlusions.
This process also ensured that the sequence was complete and no images were
missing.
 For each image of the sequence the device was programmed to display for
the clinician the name of the view to be acquired (eg. "both feet, plantar
view") and an outline of this view was overlaid onto the live image to help
them capture the foot image in a standard orientation so that the subsequent
warping process described in chapter 2 involved as little deviations as possible.
To the best knowledge of the author this was the rst time that such an enforced
and controlled imaging sequence was used in a clinical trial. As a result the vast
majority of image sequences complied fully to the protocol and virtually all images
could be included in the analysis.
In each view, several ROIs are dened to resemble spot measurements taken with a
Dermatemp 1001 spot thermometer (accepted as the "gold standard" at the time of
writing) for cross-referencing. The room temperature was recorded at the beginning
and the end of each patient's visit.
In the rst trial, this sequence was imaged in quick succession and after each view.
The sequence was then repeated and nally, three more plantar images were imaged
to assess the repeatability of the infrared camera device. In the second trial the image
sequence changed by removing the last three plantar images because repeatability
was already established by the results from the rst trial.
The rst trial ended at the end of September/beginning of October 2015 and con-
tributed 109 normal (control) image data sets. Figures 3.1 and 3.2 show a sample
of the images that were taken. Figure 3.1 and the associated ROI data plots in
gure 3.3 demonstrate that a simple comparison between left and right foot, as often
indicated in literature [8, 9, 10, 11, 12], is not sucient to condently predict a foot
ulcer. Moreover, in gure 3.2, an abrupt change in temperature can be observed
between the 5th and 7th minute. It was later found that the volunteer was an active
footballer, a sport that can exert high asymmetric stresses on the feet. Physiological
adaptation to these stresses may explain the sudden change in observed temperature.
In their totality the results from both trials demonstrated:
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 A simple left-right temperature comparison on its own is one potential indica-
tion of a developing foot ulcer but other corroborating factors are required to
achieve a reasonable specicity
 A simple hot spot denition such as a particular area of the foot being 2.2 ◦C
warmer than the average of the respective foot is also on its own not a reason-
ably reliable predictor
 A single thermal imaging session approximately every 4 weeks is not sucient
to capture the onset of ulceration for most patients
The data and reasoning for the above 3 statements together with a suggested im-
proved methodology for detecting the onset of ulceration is provided in chapter 4.
Before that the remaining sections of this chapter outline the hardware and espe-
cially the software produced by the author incorporated into the imaging device that
helped the clinical team to arrive at the above results.
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(a) First plantar image (t=0 min)
(b) Fifth plantar image (t=20 min)
Figure 3.1: Healthy volunteer showing asymmetry between left and right plantar
view at the beginning and at the end of a 20 minute examination
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(a) Second plantar image (t=5 min)
(b) Second dorsal image (t=7 min)
Figure 3.2: Healthy volunteer showing sudden temperature change within 2-3
minutes
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(a) Comparison of the Big Toe
(b) Comparison of the First Metatarsal Head
(c) Comparison of the Heel
Figure 3.3: Data from Areas of Interest from volunteer in gure 3.1
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3.2 Measuring Device
3.2.1 Device Hardware
The Diabetic Foot Ulceration Prevention System (DFUPS) device built using the
specications in table 3.1 is shown in an exploded plan of the device (gure 3.4). One
of the web cameras was eventually not useable due to USB bandwidth limitations and
was replaced by a speaker to provide audible feedback for the clinician when an image
had been saved (articial shutter sound). Two angled green Light Emitting Diodes
(LEDs) projectors underneath the openings for the webcameras allowed for a correct
distance to the target by triangluation i.e. when the two projected green dots did not
overlap, the distance was not correct. For the duration of the study, there were four
imaging devices and three laptops available to the hospitals. Shortly after the devices
were built by Photometrix Ltd. (one of the collaborating partner in this project),
they were sent to the National Physics Laboratory (NPL) to characterise the infrared
cameras for their drift over time, temperature dierence to the ITS-90 scale and the
correction thereof. The three cameras that showed the least drift in temperature
over time were sent to the hospitals. The last instrument was kept as a spare in case
of problems with a dierent device. The process of characterisation was repeated 3
times throughout the study, before trial 1, between trial 1 and 2 and at the end of
trial 2. The results were stored as a linear equation per device per characterisation
and later applied to the data before analysis using linear interpolation across the
time scale to account for the drift eect of the cameras. This eect was in the range
of -2.8% to 0%, where the percentage refers to the measured value, in addition to a
static bias between 0.7 ◦C to 2.4 ◦C.
Component Name
Computing Platform Odroid-U3
Infrared Camera Micro-Epsilon TIM-400
Webcamera #1 Odroid USB-Cam 720P
Webcamera #2 Unavailable due to USB bandwidth issues
Table 3.1: Current Device Components
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Figure 3.4: DFUPS Exploded Plan - One of the web cameras was not useable
due to USB bandwidth limitations and was replaced by a speaker
3.2.2 Device Software
The software for the imaging device was planned and developed by the author to
allow the clinicians to enter details about a patient when he or she enters the trial,
take images and pull images o of the device and onto a USB stick. Figure 3.5 shows
the simplied ow chart outlining the control ow of the program. It shows some of
the technical details for other features of the device such as automated recovery in
the event that it crashes. Figure 3.6 shows screenshots of the device software and
the software that runs on the laptops for the extraction of regions of interest and
outlining of the feet.
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Figure 3.5: Flow chart of the Software running on the DFUPS device
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(a) Device Software with a 50-50 mix between the infrared and visible spectra
(b) Laptop software to place Areas of Interest
(c) Laptop software to place Outline Control Points
Figure 3.6: Screenshots of the Device and Laptop Software
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The device software makes use of various libraries to be able to function correctly.
These include QT5 for the graphical display, OpenCV for the capture of images from
the attached webcamera and a proprietary library written by Micro-Epsilon GmbH
for the infrared camera [33, 34]. The development was done using the device itself and
a networking cable to communicate with the device using the secure shell protocol
(SSH). The SSH protocol allows the control of a remote computer over a network
and the passing of data through it. This method is called tunnelling and can be used
with the default graphical interface of Linux (X server) to display and manipulate
graphical programs such as QT Creator, QT's Integrated Development Environment
(IDE). Within QT, there is an automation program called qmake for the generation
of information on how to compile a project. The tool can be congured in a le and
was used to link in the aforementioned external libraries.
To keep the development and operation of the device secure, the only method to login
over the network is restricted to public-private key pairs, which is a superior method
of authentication than a plain password when it comes to security. Although the
network side of the device is secured, it is not secured from physical attacks, such as
starting the device from a USB stick or worse, plugging in a keyboard and executing
codes manually. The risk of physical entry is elevated by the fact that the user
running the program has root access. However, this device does not attempt to
connect to a network nor does it allow the user to input credentials to a network, so
a physical attack will only result in the device being stolen. This poses a dierent risk
altogether, as sensitive data may be stored on the devices. This is mitigated by using
as little as possible identifying data in the clinical protocol. The only data related to
the patients that is stored on the device are the images, the anonymised trial identier
and the patient's data of birth. Even with these measures it is still theoretically
possible to correlate the data from the device with data obtained elsewhere, but the
likelihood of this happening is very low and the practical diculties of doing so are
very high.
The software that runs on the device saves images in a special le format. It utilises
the existing JPEG File Interchange Format (JFIF) standard [35] and adds additional
information to the end of the le. This is possible due to the existence of start and
end markers in the specication. Programs and Operating Systems are still able to
read and display the JPEG image but have no knowledge of the appended data. The
complete le structure is as follows:
1. Visual image JPEG
2. Infrared image JPEG
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3. A le format version string (3 bytes in ASCII format, for example 1.6)
4. Width and height of the infrared image (expressed as <width>x<height>px)
5. Width and height of the visual image (expressed as <width>x<height>px)
6. The temperature data (array of 16-bit values, little endian format)
7. the green channel data of the visual image (in eect a monochrome image, an
array of 8-bit values)
8. Extensible Markup Language (XML) format containing:
(a) Image identier in the series described in the clinical protocol (for example
P1, S1-PL2, D1, etc.)
(b) An image timestamp
(c) ID of the hospital (KIN, PEN or FRH)
(d) ID of the operator
(e) Anonymised ID of the patient
(f) Visit number (starting at 0)
(g) Temperature readouts of the infrared camera (shutter, housing and chip)
(h) Date of birth of the patient as three separate entries
(i) Group of the patient as described in 3.1
(j) Areas of interest (added manually on the laptop) as a list of:
i. Normalised x coordinate
ii. Normalised y coordinate
iii. Normalised radius
iv. Mean temperature
v. Flag if the ROI is an ulcer
vi. Flag if the ROI is tentative (to be decided if ulcer or not)
(k) Outline of the foot as a list of:
i. Normalised x coordinate
ii. Normalised y coordinate
iii. Normalised radius
(l) Data referring to the user interface on the laptop:
i. Overlay x position (visual image oset relative to the infrared pro-
gram)
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ii. Overlay y position (visual image oset relative to the infrared pro-
gram)
iii. Overlay opacity
iv. Flag to show only the visual image
v. Number for the thresholding of the temperature data for visual eect
vi. Beginning of the colour scale
vii. End of the colour scale
The advantage of using a format that ts into one le is the organisation and moving
of the data within an operating system but the downside is that special code is needed
to read out the data. Hence another program is needed to extract the data from the
le into dierent formats such as CSV.
Figure 3.6a shows a screenshot of the device software with the capturing screen.
This software was written to be used on a touchscreen hence the buttons were made
to be large to allow ease of use. The black bar at the bottom of the window is
the battery charge level indicator, which was disconnected at the time, therefore
showing 0% charge. Located on the left side is the ordered series of images that
needed to be taken, mirrored from the clinical protocol (see section 7.2). A review
policy encoded in the software enforces the clinician to look through the images
before saving them (fullled with the "Up" and "Down" buttons). In the list of
image identiers (an abbreviated code for the foot view), green represents an image
that has been saved to a temporary directory, blue the current index and white the
images that have yet to be taken. To the immediate right is a slider that allowed the
mixing of the infrared and visual images to be controlled. This was achieved using
the XOR composition mode oered by QT's QPainter class and setting the opacity
of the images to V isualopacity = opacity and Infraredopacity = 1 − opacity, where
the opacity is a percentage expressed as a value between 0 and 1. To the right of
the image is the colour scale of the thermal image, which is xed between 15 and
40 ◦C; a range that was decided on by the i4i consortium early into the study to be
able to compare images to each other visually, a feature that became important for
the hospital's own anaylsis process. Lastly, on the right side of the window are the
controls for taking images. When the "Capture" button is pressed, the index in the
image sequence list is not immediately incremented to allow the clinician to check
the image has been taken correctly and redo the capture process if necessary before
moving on by pressing the "Down" button. After going through the entire sequence,
the program resets the image sequence index to the start of the list and requires
the clinician to look through the entire image set again before being able to save
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the sequence. When it is saved, the images from the temporary directory are moved
to the permanent directory structure from which the images can be downloaded.
An important aspect of both directories is the usage of non-volatile memory. This
enables recovery from an unexpected device state e.g. a crash or battery failure. The
program is then able to read in the non-completed series and asks the clinician if it
should be continued.
The images were periodically downloaded from the device on to USB storage media
that were able to provided hardware encryption. These used a key that needed to
be entered on the USB storage medium itself to be unlocked for use. Within the
device software there is an option to download the images. This copies the data from
the internal storage to the USB storage medium using an algorithm that recursively
iterates through the directory structure and copies les that do not exist on the
USB storage medium. This has two advantages, rstly, it minimises data transfer
and therefore speeds up the operation and secondly, it is possible that the analysis
program modies the les when plugged in to the laptop, thus changes do not get
overwritten. Even though this feature exists, the clinicians were instructed to copy
the data from the USB storage media onto their respective laptop to have the USB
storage media as a backup and the working copy on the laptop.
3.3 Analysis Software
As already indicated in chapter 2 the process of analysing the images in the two trials
is a 2-stage process. In the rst stage images have to be brought into a geometrically
standardised form by warping (see section 2.5.1). Once standardised, automated
software tools can be used to eciently gather information from individual images
in the same fast and repeatable way, e.g. to answer questions such as "what is the
average temperature of the left big toe in all plantar foot images of trial 1?".
The rst stage of the analysis process is responsible for computing standardised
images, statistical moments of each image and storing the resulting data in a format
that allows consequent processing stages to recall the data in an ecient manner.
To accomplish this, several steps are needed:
1. pre-compute barycentric coordinates for ecient warping for backward-mapping
2. outline the foot/feet in each image by placing control points at the appropriate
anatomical positions
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3. warp and store the input images as separate result images
4. further computation such as the mean and standard deviation for each warped
image
The computation of barycentric coordinates was completed in Matlab using code
taken from the bounded biharmonic weights website [36]. The weights were placed
into CSV les to be easily readable by the analysis software. Before the weights
could be applied the outline for each foot needed to be created as described in 2.5.
This was done within the analysis software (shown in gure 3.6c) which was placed
on a website to aid the speed of completion.
The website allows multiple people to outline points on the images simultaneously.
The application presents the person with a randomly selected image from a database
of as yet unprocessed images that needed to be outlined and a generic template for
29 control points per foot on the image. The person then has the choice to place the
points in the correct anatomical positions or mark the image as 'unsolvable' in case
the background is not distinguishable from the foreground. Once the image is fully
outlined it is submitted to the website and marked as nished. After the rst person
has drawn the outline onto the image, it undergoes two more rounds of validation
by dierent people in order to be sure that the people placed the outlines correctly.
In addition to verication rounds, instructions were given on the website itself for
proper control point placement. Screenshots of the website can be found in appendix
F. For the purposes of this project, students from the University of South Wales were
contracted to aid this process. After the entire process completed, the second stage
of actual image analysis could commence.
The analysis software contains several individual helper programs that can be linked
together as needed using standard unix le descriptors. A total of ve programs were
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The DFUPS_Analysis program's sole purpose is to show the images and data
graphically in a format such as the one in gure 3.6c. Although options exist within
the user interface to extract data points into the CSV format and revert to default
ROIs, these were not used due to the command line interface being being quicker
and more powerful to use, especially for scripting.
The DFUPS_Transformer program is responsible for transforming the images
from their captured state into a standardised image. This program contains options
to read in a specic conguration le for the barycentric coordinates, set the width
and height of the output images, rotate all outline control points (created using the
website program in stage 1) by a specied amount and ip x and y coordinates.
It features the use of threading to speed up processing, as this program runs over
thousands of les, it can take a day to complete when using only a single processing
core. Each pixel that is not within the outline is set to a value lower than absolute
zero (−273.16 ◦C) to denote that it is not part of the foot.
The DFUPS_Interpolation_Comparator programs was implemented to create
the graphs shown before in gures 2.6 and 2.7 as examples. It calculates the mean
and standard deviation of each input image and outputs a CSV le containing the
resulting statistical data.
The DFUPS_Convoluter program is used for image manipulation tasks. This
program uses a Parser Generator called JavaCC [37] to include an expression parser
to manipulate pixels or extract data from the entire input image using a mathemat-
ical expression; for example $1-$2 would mean subtract input image number 2 from
input image number 1. The program implements a queuing system to allow oper-
ations to take place in a one-to-many relationship fashion, for example subtracting
multiple input images from one mean image. This works by implementing a list of
queues where every queue except the rst one is circular and thus never run out
when dequeued. The variable naming that is used is a dollar sign followed by the
queue number. If the variable has the sux "i", it is treated as the entire image.
This is useful when calculating statistical values within an image for example using
avg($1i)−$1 calculates the dierence of each pixel to the images mean temperature.
TheDFUPS_Tools program is responsible for extracting and injecting information
into the les. It contains options such as extract the images into known data les
such as png, extract temperature data based on ROIs, inject ROIs, select a colour
palette and dene xed min and max temperature for scaling.
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Each piece of analysis helper software outlined above can read and write the le
format mentioned in section 3.2.2. The output is however strongly dependent on
the parameters passed to the program. For the analysis itself, these programs were
used to transform and extract ROIs such as those shown in gure 4.1 into CSV les.
The numerical data can then be read in by Matlab to analyse using a large amount
of dierent approaches that will be detailed in the following chapter 4 to nd an
optimum distinction separation line between an ulceration and non-ulceration, some
of which are:
1. Dierence of absolute temperature between left and right foot
2. Dierence of absolute temperature to the baseline data from trial 1
3. Dierence of absolute temperature to intra-foot mean:
4. Dierence in temperature over time
The following chapter will analyse the data using standard techniques such as Thresh-
olding and Receiver Operator Curves. Other methods such as K-Means Clustering,
Support Vector Machines and Genetic Algorithms were attempted but were found to
be completely unsuitable to the task and are therefore omitted from this dissertation.
Chapter 4
Results
The results documented in this thesis are produced from the infrared image datasets
provided by the three involved hospitals. To extract the data from these images
after the pre-processing stages outlined in chapter 2 (calibration drift adjustments,
segmentation and warping of images into a standard shape) two further steps are
necessary; the denition of ROIs and ltering outliers based on how an ulcer occurred.
The rst step is shown in gure 4.1 with the denition of 12 ROIs that were taken
into consideration, they were named:
1. 1st, 2nd, 3rd, 4th and 5th Toe
2. 1st, 2nd, 3rd, 4th and 5th Metatarsal Head (MTH)
3. Metatarsal Base (MTB)
4. Heel
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Figure 4.1: Denition of Regions of Interest
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According to [38, 39] patients with a previous healed ulcer have a chance of 15-60%
of ulcerating again the following year and, as table 4.1 shows, with 33 out of the 112
included patients (29%) this was close to the numbers seen in this trial.
The second step was accomplished by classifying each ulcer into three types of oc-
currence, Biological, Behavioural and Mixed. The rst type describes ulcers that
occurred due to underlying biological problems, the second refers to ulcers that oc-
curred due to various interferences such as a heavy object falling onto a patients foot,
walking barefoot on a hot beach and prolonged walking. The last type describes a
mix between the two in cases where the patient followed the medical advice partially
and the cause of the ulcer can be attributed both to underlying and behavioural
causes. An example of such a case is prolonged walking in surgical shoes.
After each ulcer was classied, all ulcers that fell into the Behavioural and Mixed
groups were removed from the result set since behavioural ulceration is incidental
and thus impossible to predict by any technology. Of the remaining 12 ulcerations
shown in table 4.2, one ulcer formed after the rst visit to the clinic hence making the
data unt for time-based analysis and was therefore also left out of the dataset. The
data for the remaining 11 ulcers was thereafter extracted by calculating the mean
of each area of interest and written to a comma separated value le from which it
could be read in and analysed using a statistical package.
- KIN FRH PEN Total
Number of Patients 63 47 21 131
Number of Group A 25 16 9 50
Number of Group B 35 18 9 62
Number of Group C (rejected) 3 13 3 19
Ratio Group A:Group B 1:0.71 1:0.89 1:1 1:0.81
Number of ulcers 20 7 6 33
Biological cause of ulceration 4 4 4 12
Behavioural cause of ulceration 9 3 2 14
Mixed cause of ulceration 7 0 0 7
Table 4.1: Breakdown of trial 2 Hospital Statistics
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No. Hospital Identier Group Number of Visits Ulcer site
1 KIN 002MIR A 18 Right 4th MTH
2 KIN 006JAW A 10 Right 5th MTH
3 KIN 031MAF B 2 Left and right 1st Toe
4 KIN 045CAO B 5 Left 3rd Toe
5 FRH 013WJE B 4 Left 4th Toe
6 FRH 037VTH A 5 Right Metatarsal Base
7 FRH 001DT_ A 4 Left 1st Toe Nailbed
8 FRH 045BPH A 9 Left 2nd Toe Apex
9 PEN 005WT_ A 3 Left 2nd Toe Apex
10 PEN 012JE_ B 2 Right 1st Metatarsal Head
11 PEN 013AC_ A 2 Right 5th Metatarsal Head
12 PEN 002MM_ A 1 Left 2nd Toe
Table 4.2: Breakdown of the 12 Biological ulcer patients included in the data
set for analysis, patient 12 not included in the analysis due to almost immediate
ulceration after only 1 visit
The following gures 4.2 through 4.6 show data plots of the dataset generated using
the analysis helper programs described in section 3.3. Additionally a baseline image
was calculated from the data from trial 1. The full set of data plots are in appendix
A. To seek out which classiers may be suitable for identifying or even predicting
ulceration, the data was plotted using 5 potential classiers:
1. ROI temperature (TROI)
2. Temperature asymmetry (abs(Tleft − Tright))
3. Temperature variance (Tspot − Tmean)
4. Temperature change over time (Tcurrent visit − Tprevious visit)
5. Dierence to baseline (Tspot − Ttrial 1 Mean Image)
Each of the potential classiers is one-dimensional, meaning that in the following
data plots (Figure 4.2, 4.3, 4.4, 4.5 and 4.6), the x coordinate is an arbitrary
number given to each data point. Data points where ulceration occurred during trial
two are marked in red and data points where ulceration did not occur during trial
two are marked in black. Furthermore, to ease visual assessment, all data points are
displayed as their absolute (dierence to zero) values as well as sorted by ulceration
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data i.e. the rst n data points represent data where an ulcer eventually occurred
and the following m data points represent data where an ulcer did not occur.
Figure 4.2 shows the extracted data points as absolute temperatures. Each data
point occurred at any given point in time during trial 2. Red data points represent
patients that eventually ulcerated at a given ROI and black data points represent
ROIs that did not ulcerate. Figure 4.2a shows that most of the ulcerated ROIs
tend to have an elevated temperature, but not consistently so and not to such a
degree that they are unambiguously distinguishable from non-ulcerated data points.
Figure 4.2b shows the data points only for the 1st Toe but it also shows a similar
pattern to gure 4.2a. However, most data points where ulceration occurred lie above
T > 34 ◦C. These results point towards a detection/prevention approach that uses
"high temperature" as one of its inputs.
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(a) ROI temperature plot - all ROIs
(b) ROI temperature plot - 1st Toe only
Figure 4.2: ROI temperature plots
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Figure 4.3 shows plots of the temperature asymmetry classier. Each dot represents
a data point calculated as the absolute value of any ROI but this time subtracted
from its contralateral ROI, i.e. showing the dierence in ROI temperature between
left and right corresponding ROIs. The black line marks the current accepted 2.2 ◦C
gold standard threshold for ulcer prediction. The ulcerating cohort data does not
show any obvious dierence to the non-ulcer cohort data indicating that the 2.2 ◦C
threshold could be too simplistic.
Figure 4.3a shows in fact that there are many false positive and false negative results,
displayed as black dots above the black line and red dots below the black line,
respectively. Figure 4.3b shows extreme cases where simple temperature asymmetry
is unsuitable for ulcer detection/prediction. In this gure, all ulcerated points are
close to a 0 ◦C dierence which, according to the 2.2 ◦C model, would falsely indicate
near-perfect conditions.
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(a) Temperature asymmetry plot - all ROIs
(b) Temperature asymmetry plot - 1st Toe only
Figure 4.3: Temperature asymmetry plots
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Figure 4.4 presents the extracted data as a plot of the ROI temperature subtracted
from the foot mean temperature, which is calculated across the entire foot (not just
the ROIs). The data points in gure 4.4a where ulceration occurred are spread out
over the entire y axis range, with a grouping of points around the 1.5 to 2.5 ◦C range.
However, the non-ulcerated data points are also spread out over the entire y range,
with most data points being within the lower half (T < 2.2 − 2.3 ◦C). This trend
continues when the data is split into ROIs such as in gure 4.4b.
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(a) Temperature variance plot - all ROIs
(b) Temperature variance plot - 1st Toe only
Figure 4.4: Temperature variance plots
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Figure 4.5 displays the data calculated as a time-based previous temperature mea-
surement of an ROI subtracted from the current temperature measurement of the
same ROI. This calculation generates a delta temperature for each ROI over time.
Figure 4.5a shows that most of the ulceration cohort data is grouped below 2 ◦C,
whereas the non-ulceration cohort data covers the whole y range but most of the
data points are below 4 ◦C. Figure 4.5b shows the potential that a classier for
temperature uctuation could have. The two ulceration cohort data points lie above
most of the non-ulceration data points, but many of the non-ulceration cohort data
points are within the same band (2.5 ◦C < T < 4.1 ◦C) as the ulceration cohort data.
Furthermore, there are also data points above the ulceration data points. A simple
"last visit minus current visit" temperature drift measurement is therefore unlikely
to contribute to a detection/prediction tool - especially if measurements are made at
the rather long monthly intervals as in this study. Shorter intervals, e.g. daily, may
produce a dierent outcome.
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(a) Temperature change over time plot - all ROIs
(b) Temperature change over time plot - 1st Toe only
Figure 4.5: Temperature change over time plots
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Figure 4.6 shows the data points calculated as the baseline image ROI subtracted
from the measured ROI data point, per ROI. The underlying idea is that an increase
in the the dierence to a normal foot over time might indicate the onset of ulceration.
However, gure 4.6a shows that the ulceration data is spread out over the whole
range with some groupings at T > 6 ◦C. This is similar to what was shown before in
gure 4.2 but with less precision. Figure 4.6b shows the data points for the 1st Toe
ROI only. It also shows that the non-ulceration cohort data can almost entirely be
mistaken for noise.
From these 10 gures is it apparent that there is no obvious simple way to use any
of the 5 classiers on its' own for reliable ulcer identication or prediction. The
following chapter 5 therefore combines the information provided by the classiers
attempting to establish a particular combination that might reveal so far hidden
characteristics or patterns.
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(a) Dierence to baseline plot - all ROIs
(b) Dierence to baseline plot - 1st Toe only
Figure 4.6: Dierence to baseline plots
Chapter 5
Analysis and Discussion
The data presented in chapter 4 is based on 5 distinct parameters to classify the
data into two groups: 'Did ulcerate' and 'Did not ulcerate'. To recall, these were:
1. ROI temperature (TROI)
2. Temperature asymmetry (abs(Tleft − Tright))
3. Temperature variance (Tspot − Tmean)
4. Temperature change over time (Tcurrent − Tprevious visit)
5. Dierence to baseline (Tspot − Ttrial 1 Mean Image)
The methods that will be tested as a classier in this chapter are:
1. Temperature asymmetry threshold (currently accepted gold standard approach)
2. Graphical assessment of all combinations using 2 parameters
3. Area under the curve of receiver operator curves
5.1 Temperature Asymmetry Threshold
Chapter 4 already indicated that the simple 2.2 ◦C threshold frequently cited in
literature and today's de-facto "gold standard" might not be an ideal classier for the
data obtained in this study. In order to conrm this suspicion the data was subjected
to Receiver Operator Curve (ROC) analysis. The ROC space is constructed by
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plotting the true positive rate (TPR or sensitivity) over the false positive rate (FPR
or 1 - specicity) and results in diagram such as that shown in gure 5.1.
Figure 5.1: Receiver Operator Curve explanatory diagram, from [40]
In gure 5.1 the ROC Space is divided into two halves by the red dashed line which
indicates the predictive value of a set of random guesses. A ROC located above this
line represents a classier that is better than random guessing. A perfect classier is
represented by a straight line from the origin in the lower left corner to point (0,1)
in the upper left hand corner and from there to point (1,1) in the upper right corner.
If the ROC is reected over the dashed line i.e. from the origin to point (1,0) and
on to point (1,1) then the classier needs to be inverted. For example, consider an
experiment to determine the relationship between the temperature and state of water
(under 'normal', sea-level atmospheric pressure) and a classier for the state of water
that states Statewater = liquid, if Temperaturewater < 0
◦C is tested. A Receiver
Chapter 5 - Analysis 61
Operator Curve would be below the red dotted line, indicating that the classier is
suitable to determine the state of water but that the threshold is falsely interpreted.
This means that the classier should be Statewater = liquid, if Temperaturewater >
0 ◦C. With the updated threshold, the ROC would show a near-perfect classier.
A method to numerically determine how suitable a classier is using a ROC is the
area under its curve. By this method, a classier that randomly guesses as shown by
the red dotted line in gure 5.1 would score a value of 0.5. A perfect classier would
show a value of 1 and a falsely interpreted threshold as in the above state-of-water
experiment would have an area under the curve close to 0.
Using the trial data generated in this study a ROC can be generated for a range
of contra lateral dierence temperatures between ∆T=0 ◦C and ∆T=10.7 ◦C. The
resulting plot is shown in gure 5.2. The maximum distance of the curve from
the random guess line i.e. the point where the predictive powers are best is in the
area around TPR = 0.5 and FPR = 0.2. This corresponds to a ∆T of 2 ◦C for
the data obtained in this trial and this conrms the before mentioned 2.2 ◦C contra
lateral dierence which is the current 'gold standard' for predicting the occurrence
of diabetic foot ulcers.
However, as table 5.1 shows, at ∆T=2.0 ◦C the sensitivity of the method is only
about 45 % which means that more than half of the potential ulcer developments are
missed. Those 45 % that are being highlighted by the threshold are then 80 % likely
to be correctly classied. Moreover, the positive predictive value (PPV) was only
8.9 %.
This result demonstrates two things:
1. the 2.2 ◦C threshold is close to the ndings in this study and could be conrmed
2. the predictive value (sensitivity) at reasonable reliability (specicity) of the
2.2 ◦C threshold is low
This second outcome means that other parameters should be tested if they can
be combined with the 2.2 ◦C threshold in order to improve both sensitivity and
specicity. This is done in the following sections of this chapter.
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Figure 5.2: Analysis of the ROI temperature Dierence Threshold value using a
Receiver Operator Curve for dierences between 0 and 10.7 ◦C. The best classi-
cation on trial data is achieved in the area around ∆T = 2.0 ◦C.
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Threshold TPR (%) TNR (%) PPV (%) NPV (%)
0.1 98.1 5.9 4.3 98.6
0.2 96.2 13.3 4.6 98.8
0.3 90.4 19.0 4.6 97.8
0.4 86.5 25.4 4.8 97.7
0.5 75.0 31.8 4.6 96.7
0.6 73.1 38.0 4.9 97.0
0.7 71.2 42.0 5.1 97.1
0.8 71.2 47.0 5.5 97.4
0.9 63.5 51.2 5.3 97.0
1.0 63.5 55.2 5.8 97.2
1.1 59.6 58.4 5.9 97.1
1.2 57.7 61.9 6.2 97.1
1.3 51.9 65.2 6.1 96.9
1.4 50.0 67.9 6.3 96.9
1.5 46.2 69.7 6.2 96.8
1.6 46.2 72.3 6.8 96.9
1.7 46.2 74.4 7.3 96.9
1.8 46.2 76.3 7.8 97.0
1.9 46.2 78.3 8.5 97.1
2.0 44.2 80.3 8.9 97.1
2.1 44.2 81.4 9.3 97.1
2.2 40.4 82.4 9.1 96.9
2.3 40.4 83.7 9.7 97.0
2.4 38.5 84.7 9.9 96.9
2.5 32.7 85.6 9.0 96.7
2.6 32.7 86.4 9.4 96.7
2.7 30.8 87.5 9.6 96.7
2.8 28.8 88.5 9.8 96.6
2.9 25.0 88.8 8.8 96.5
3.0 23.1 89.4 8.6 96.4
Table 5.1: Statistical measures for Various ROI temperature Dierence Thresh-
olds - Simple Method (in bold: optimum ∆T values according to literature
(∆T=2.2 ◦C as per [12]) and as found in this study (∆T=2.0 ◦C))
Chapter 5 - Analysis 64
5.2 Combining Parameters
Relying on single parameters to classify data was shown to be unsatisfactory in
chapter 4. Nonetheless for each of the parameters there is a corresponding ROC
that may be evaluated before moving on to attempting to combine the parameters.
The evaluation data is located in tables 5.3 and 5.4, the graphical representation for
all data is in gures 5.3 to 5.5 and the ROCs for each ROI are in appendix B. In
each graphical representation, the minimum, maximum and farthest-from-random-
guess threshold values are highlighted. The aforementioned measure of classier
strength, Area under the Curve (AUC), is used to compare the the classiers. The
results in tables 5.3 and 5.4 show that the most suitable candidates according to the
AUC are the ROI temperature and the dierence to baseline with values of 0.72 and
0.73. This is still far from an ideal classier also shows that there is some potential.
The other classier AUCs are in the range of 0.42 to 0.67. Splitting up the data
into the respective Regions of Interest (Figure 4.1) increases the classier strength
at almost all ROIs. This suggests that each region of interest needs to be treated
separately. Furthermore, in some cases, the AUC value is lower than 0.5, suggesting
that at specic ROIs, the classiers need to be inverted. This is counter-intuitive for
example with temperature asymmetry in the 1st or 2nd Toe but may be explained in
this particular case by the small sample size. However, the cost of splitting up the
data decreases the positive sample size. In some cases, the ulceration cohort data
sample size drops as low as two data points.
Prior to combining the parameters, each parameter was tested for a range of threshold
values to establish a baseline. The resulting values for sensitivity and specicity are
outlined in table 5.2. Some abbreviations were used in the threshold values due to





Temperature change over time Tchange
Dierence to baseline ∆Tbaseline
The highest sensitivity values that also keep the specicity above 90% were 51.2%
with 33.5 < TROI , 48.8% using 6.0 < abs(∆Tbaseline), 44.2% using 1.0 < abs(Tvariance)
and 39.5% using 2.0 < abs(Tasymmetry). These values can be further optimised by
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tweaking the threshold values but they provide a baseline what to expect when com-
bining the classiers. In the following comparisons, the classier 33.5 < TROI is used
as the 'best baseline classier'.
Threshold TPR (%) TNR (%)
33.0 < TROI 51.2 88.4
33.5 < TROI 51.2 92.4
34.0 < TROI 44.2 96.0
34.5 < TROI 23.3 98.3
0.5 < abs(Tasymmetry) 55.8 65.8
1.0 < abs(Tasymmetry) 53.5 77.6
1.5 < abs(Tasymmetry) 39.5 84.9
2.0 < abs(Tasymmetry) 39.5 90.1
2.5 < abs(Tasymmetry) 32.6 92.8
3.0 < abs(Tasymmetry) 20.9 94.6
3.5 < abs(Tasymmetry) 14.0 96.2
4.0 < abs(Tasymmetry) 14.0 97.3
0.5 < abs(Tvariance) 53.5 79.3
1.0 < abs(Tvariance) 44.2 90.1
1.5 < abs(Tvariance) 32.6 95.7
2.0 < abs(Tvariance) 16.3 98.7
2.5 < abs(Tvariance) 2.3 99.4
abs(Tchange < 0.5) 34.9 75.9
abs(Tchange < 1.0) 46.5 59.0
abs(Tchange < 1.5) 62.8 46.0
abs(Tchange < 2.0) 79.1 35.8
abs(Tchange < 2.5) 81.4 26.0
6.0 < abs(∆Tbaseline) 48.8 91.8
6.5 < abs(∆Tbaseline) 32.6 94.7
7.0 < abs(∆Tbaseline) 20.9 97.4
7.5 < abs(∆Tbaseline) 18.6 99.1
8.0 < abs(∆Tbaseline) 9.3 99.9
Table 5.2: Sensitivity and specicity for various classiers
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(a) ROC for the ROI temperature data in gure 4.2a
(b) ROC for the temperature asymmetry data in gure 4.3a
Figure 5.3: Receiver operator curves for gures 4.2 and 4.3
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(a) ROC for the temperature variance data in gure 4.4a
(b) ROC for the temperature change over time data in gure 4.5a
Figure 5.4: Receiver operator curves for gures 4.4 and 4.5
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(a) ROC for the dierence to baseline data in gure 4.6a
Figure 5.5: Receiver operator curves for gures 4.4
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Parameter Description ROI Data Size AUC
ROI temperature All ROIs 43 0.73
Temperature asymmetry All ROIs 86 0.68
Temperature variance All ROIs 43 0.59
Temperature chance over time All ROIs 42 0.42
Dierence to baseline All ROIs 43 0.72
ROI temperature 1st Toe 2 0.18
ROI temperature 2nd Toe 9 0.88
ROI temperature 3rd Toe 3 0.16
ROI temperature 4th Toe 2 0.41
ROI temperature 4th MTH 16 0.95
ROI temperature 5th MTH 8 0.54
ROI temperature 5th MTH Base 3 0.86
Temperature asymmetry 1st Toe 2 0.17
Temperature asymmetry 2nd Toe 9 0.39
Temperature asymmetry 3rd Toe 3 0.70
Temperature asymmetry 4th Toe 2 0.66
Temperature asymmetry 4th MTH 16 0.93
Temperature asymmetry 5th MTH 8 0.70
Temperature asymmetry 5th MTH Base 3 0.28
Table 5.3: Statistical values for the ROCs presented in appendix B
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Temperature variance 1st Toe 2 0.59
Temperature variance 2nd Toe 9 0.42
Temperature variance 3rd Toe 3 0.55
Temperature variance 4th Toe 2 0.16
Temperature variance 4th MTH 16 0.94
Temperature variance 5th MTH 8 0.28
Temperature variance 5th MTH Base 3 0.25
Temperature chance over time 1st Toe 2 0.79
Temperature chance over time 2nd Toe 8 0.19
Temperature chance over time 3rd Toe 3 0.59
Temperature chance over time 4th Toe 2 0.75
Temperature chance over time 4th MTH 16 0.25
Temperature chance over time 5th MTH 8 0.61
Temperature chance over time 5th MTH Base 3 0.71
Dierence to baseline 1st Toe 2 0.21
Dierence to baseline 2nd Toe 9 0.86
Dierence to baseline 3rd Toe 3 0.32
Dierence to baseline 4th Toe 2 0.21
Dierence to baseline 4th MTH 16 0.95
Dierence to baseline 5th MTH 8 0.50
Dierence to baseline 5th MTH Base 3 0.85
Table 5.4: Statistical values for the ROCs presented in appendix B continued
To combine the parameters, it is rst necessary to visually compare the data by
graphing the parameters against each other. Figures 5.6 to 5.15 show the graphs that
put each parameter against each other parameter. The second step is to manually
dene thresholds or threshold ranges that look like they could separate the data in a
meaningful way. These thresholds are then tested for their respective sensitivity and
specicity. The statistical data is given in the format "TPR, TNR" in each of the
tables 5.5 through 5.13. From there, it may be possible to combine three or more
threshold values to improve the sensitivity and specicity even further.
Figure 5.6 shows the ROI temperature data graphed against the temperature asym-
metry. The temperature asymmetry is calculated as the dierence between contra
lateral ROIs, where the ulceration cohort data is separate for left and right. This
means that for each data point on a foot that ulcerated there is also a temperature
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asymmetry value on the non-ulcerated, other foot that is equal but with the opposite
sign. The same principle applies when an ROI on the right foot ulcerated. The data
points then results in symmetry across the y axis, but shifted by the x axis. In this
graph, most of the ulceration cohort data is above 33 ◦C but does not show a clear
separation along the y axis. However, it is noticeable that every ulceration cohort
point above 33 ◦C has a temperature asymmetry that is above 0 ◦C. Using a variable
threshold for the ROI temperature between 33 and 34.5 in 0.5 steps together with
the two temperature asymmetry denitions 0 < Tasymmetry and 0 < Tasymmetry < 5
yields the data in table 5.5. The best result is achieved by a ROI threshold of
33.5 ◦C and a positive temperature asymmetry, with a sensitivity and specicity of
51.2% and 94.3%, respectively. This value is higher than the best baseline classier
(33.5 < TROI) in that it increased the specicity value by 1%.
Figure 5.6: ROI temperature vs. temperature asymmetry plot
y < TROI threshold 0 < Tasymmetry 0 < Tasymmetry < 5
33.0 51.2, 91.6 44.2, 92.2
33.5 51.2, 94.3 44.2, 94.6
34.0 44.2, 96.7 37.2, 96.8
34.5 23.3, 98.4 20.9, 98.4
Table 5.5: ROI temperature vs temperature asymmetry threshold assessment
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Figure 5.7 graphs the ROI temperature against the temperature variance. The data
appears to be striped because the temperature variance is calculated using the ROI
temperature and thus directly dependent on the ROI temperature. In this graph a
grouping of points near the top right hand corner is visible. Most of the ulceration
cohort data points are located above 0 ◦C to 1 ◦C temperature variance and above
33 ◦C. The sensitivity and specicity data when using thresholds of 0 ◦C to 2 ◦C in
0.5 steps for the temperature variance and 33 ◦C to 34.5 ◦C for the ROI temperature
is shown in table 5.6. The table shows the threshold with the highest sensitivity and
specicity is between TROI > 33.5 in combination with Tvariance > 0 with 51.2%
and 92.9%, respectively. This is a slight decrease in specicity compared to the ROI
temperature and temperature asymmetry approach but almost equal to the baseline.









0.0 0.5 1.0 1.5 2.0
33.0 51.2, 89.8 46.5, 92.2 39.5, 95.9 32.6, 98.2 16.3, 99.6
33.5 51.2, 92.9 46.5, 94.3 39.5, 96.6 32.6, 98.5 16.3, 99.6
34.0 44.2, 96.1 39.5, 96.7 32.6, 97.6 27.9, 98.9 11.6, 99.7
34.5 23.3, 98.3 23.3, 98.3 16.3, 98.7 16.3, 99.3 7.0, 99.8
Table 5.6: ROI temperature vs temperature variance threshold assessment
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Figure 5.8 shows the ROI temperature graphed against its respective change over
time. The graph shows a grouping of positive points with high ROI temperature
and low change over time.This leads to using the same ROI temperature thresholds
as previously and thresholds for the temperature change over time in the region of
0.5 ◦C to 2.5 ◦C in steps of 0.5. The results are in table 5.7. The combination of
thresholds that stands out in this data are 33.5 < TROI and −2 < Tchange < 2,
which have a sensitivity of 51.2% and 94.4% specicity. These values are almost
equal to the values obtained from the ROI temperature and temperature asymmetry
sensitivity and specicity.









< x 0.5 1.0 1.5 2.0 2.5
33.0 32.6, 96.4 39.5, 94.3 46.5, 92.7 51.2, 91.5 51.2, 90.3
33.5 32.6, 97.2 39.5, 95.8 46.5, 95.0 51.2, 94.4 51.2, 93.5
34.0 30.2, 98.2 34.9, 97.6 41.9, 97.4 44.2, 97.1 44.2, 96.7
34.5 11.6, 99.1 14.0, 98.9 20.9, 98.8 23.3, 98.7 23.3, 98.6
Table 5.7: ROI temperature vs temperature change over time threshold assess-
ment
Chapter 5 - Analysis 74
Figure 5.9 shows the parameters ROI temperature graphed against the dierence
to the baseline. This graph has a linear relationship because the two parameters
depend on each other. Hence there are also no clear threshold values that can be
obtained because it would be the same as a threshold for either the ROI temperature
or the dierence to baseline, but a combination would not.
Figure 5.9: ROI temperature vs. dierence to baseline plot
Figure 5.10 plots the temperature asymmetry parameter against the temperature
variance. There is no obvious grouping in the graph, however there are some ul-
ceration cohort data points in the top right hand corner. The threshold intervals
therefore chosen for this graph are 0.5 to 3 with a step size of 0.5 for the temperature
asymmetry and 0.5 to 1 with a step size of 0.5 for the temperature variance. The
calculated sensitivity and specicity values are shown in table 5.8. The thresholds
that obtained the highest sensitivity are 0.5 < Tasymmetry and 0.5 < Tvariance with
44.2% and 89.8%. Both the sensitivity and the specicity are lower than than in
previous thresholds and the baseline.
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0.5 44.2, 89.8 41.9, 94.0 32.6, 96.7
1.0 41.9, 92.4 39.5, 95.4 32.6, 97.3
1.5 37.2, 94.4 34.9, 96.4 27.9, 97.8
2.0 37.2, 96.2 34.9, 97.5 27.9, 98.3
2.5 30.2, 97.5 27.9, 98.3 25.6, 98.9
3.0 18.6, 98.0 16.3, 98.7 16.3, 99.0
Table 5.8: Temperature asymmetry vs temperature variance threshold assess-
ment
Figure 5.11 graphs the temperature asymmetry data against the temperature change
over time data. In this graph, the 'did ulcerate' and 'did not ulcerate' data points are
mixed too well to be able to establish an obvious threshold. There is a grouping of
points near −1 < y < 1 and x > 2, the threshold intervals chosen for this graph are
therefore between 0.3 to 1.2 with a step size of 0.3 for the temperature change over
time and 0 to 3 in steps of 0.5 for the temperature asymmetry threshold. The results
are listed in table 5.9. In these threshold ranges, the highest sensitivity is 46.5% for
0 < Tasymmetry and Tchange but the specicity drops to only 74.2%. A 20% higher
specicity is achieved with a higher threshold for the asymmetry (2 < Tasymmetry),
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where the trade-o is 10% less sensitivity. Overall, the sensitivity and specicity val-
ues are the similar to the previously explored threshold combination. However, the
sensitivity is around 20% lower than in the baseline.









< x 0.3 0.6 0.9 1.2
0.0 18.6, 91.8 32.6, 84.5 41.9, 79.1 46.5, 74.2
0.5 16.3, 94.9 25.6, 89.8 34.9, 85.5 39.5, 81.9
1.0 16.3, 97.0 25.6, 93.4 34.9, 90.3 39.5, 88.0
1.5 16.3, 98.1 25.6, 95.6 30.2, 93.5 32.6, 91.7
2.0 16.3, 98.7 25.6, 97.2 30.2, 95.9 32.6, 94.7
2.5 14.0, 99.2 20.9, 98.0 25.6, 97.1 27.9, 96.3
3.0 9.3, 99.4 14.0, 98.5 16.3, 97.8 18.6, 97.1
Table 5.9: Temperature asymmetry vs temperature change over time threshold
assessment
Figure 5.12 shows the temperature asymmetry data plotted against the dierence
to baseline data. As before when plotting the temperature asymmetry against either
the temperature variance or the temperature change over time, the data does not
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show any clear distinction between the two classes. The ulceration cohort data does
however seem to be grouped towards the bottom left hand corner of the graph. This
suggests thresholds in the region of −5 ◦C to −7 ◦C for the dierence to baseline
and 0 ◦C to 2 ◦C for the temperature asymmetry. The maximum sensitivity that
can be reached is 53.5% with a specicity of 90.5%, where the thresholds are 0 <
Tasymmetry and ∆Tbaseline < −5.5. The sensitivity is along the lines with what
the 1D classier 33.5 < TROI produced but the sensitivity is lower.






-5.0 -5.5 -6.0 -6.5
0.0 53.5, 87.5 53.5, 90.5 48.8, 94.0 32.6, 96.1
0.5 44.2, 89.9 44.2, 92.1 39.5, 95.0 23.3, 96.8
1.0 41.9, 93.0 41.9, 94.6 37.2, 96.7 23.3, 98.1
1.5 37.2, 94.3 37.2, 95.6 32.6, 97.4 20.9, 98.6
2.0 37.2, 95.7 37.2, 96.6 32.6, 97.9 20.9, 98.8
2.5 30.2, 96.9 30.2, 97.4 27.9, 98.4 18.6, 99.3
3.0 18.6, 97.5 18.6, 97.9 18.6, 98.7 11.6, 99.4
Table 5.10: Temperature asymmetry vs dierence to baseline threshold assess-
ment
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Figure 5.13 plots the temperature variance data against the temperature change
over time data. The graph presents a small grouping of the 'did ulcerate' class in the
range of 1 < Tvariance and where the temperature change over time is near zero. The
threshold intervals chosen for this combination of parameters is therefore between
0.3 and 1.2 for the temperature change over time and 0.5 to 2 for the temperature
variance. The results are presented in table 5.11. The highest sensitivity achieved
while keeping the specicity above 90% is 39.5% using thresholds of 2.5 < Tvariance
and −0.6 < Tchange < 0.6. This is lower than the previous thresholds and lower than
the best baseline classier.











0.5 1.5 2.0 2.5
0.3 18.6, 96.2 32.6, 92.2 41.9, 89.3 46.5, 86.5
0.6 16.3, 97.3 27.9, 94.3 34.9, 92.5 39.5, 91.0
0.9 16.3, 98.4 25.6, 96.5 32.6, 95.4 37.2, 94.4
1.2 11.6, 98.9 20.9, 97.8 27.9, 97.0 32.6, 96.5
Table 5.11: Temperature variance vs temperature change over time threshold
assessment
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Figure 5.14 shows the temperature variance plotted against the dierence to the
baseline. There is a grouping of ulceration cohort data points in the lower right
corner of the graph. The thresholds chosen here were in the range of -7 to -5 for
the dierence to baseline parameter and 0 to 2 for the temperature variance. Both
parameters were incremented in steps of 0.5. The results in table 5.12 show the
highest sensitivity at ∆Tbaseline < −5.5 and 0 < Tvariance with a value of 53.5%.
This is higher than the baseline while maintaining a specicity of higher than 90%,
even though it is lower than the baseline.






-5.0 -5.5 -6.0 -6.5 -7.0
0.0 53.5, 87.0 53.5, 90.6 48.8, 93.3 32.6, 95.5 20.9, 97.7
0.5 48.8, 91.2 48.8, 93.2 44.2, 95.0 27.9, 96.3 16.3, 98.1
1.0 41.9, 95.5 41.9, 96.2 37.2, 96.8 20.9, 97.8 9.3, 98.9
1.5 32.6, 98.2 32.6, 98.3 30.2, 98.6 18.6, 98.9 7.0, 99.4
Table 5.12: Temperature variance vs dierence to baseline threshold assessment
Figure 5.15 plots the temperature change over time data against the dierence to
baseline data. In this graph there is a grouping of the 'did ulcerate' class data points
in the lower area of the graph. This corresponds to a dierence in baseline below
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−5 ◦C and a temperature change near 0 ◦C. Therefore the threshold intervals chosen
for this classier range from −5 ◦C to −7 ◦C for the dierence to baseline and 0.5 ◦C
to 3 ◦C. Table 5.13 shows that the sensitivity can reach 53.5% while maintaining a
specicity of 90.8%. This is similar to the previous temperature variance vs. dier-
ence to baseline classier but achieves a higher specicity. However the specicity is
lower than in the baseline threshold data.











-5.0 -5.5 -6.0 -6.5 -7.0
0.5 32.6, 94.9 32.6, 96.2 32.6, 97.3 20.9, 98.0 16.3, 99.0
1.0 39.5, 91.8 39.5, 93.8 37.2, 95.7 23.3, 97.1 16.3, 98.6
1.5 46.5, 89.0 46.5, 92.0 44.2, 94.8 30.2, 96.5 18.6, 98.4
2.0 53.5, 87.4 53.5, 90.8 48.8, 94.0 32.6, 96.0 20.9, 98.1
2.5 53.5, 85.1 53.5, 89.3 48.8, 93.0 32.6, 95.4 20.9, 97.7
3.0 53.5, 84.4 53.5, 88.8 48.8, 92.8 32.6, 95.2 20.9, 97.7
Table 5.13: Temperature variance vs dierence to baseline threshold assessment
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5.3 Applying Thresholds to Individual Regions of Inter-
est
Using the thresholds found to be a good t in section 5.2 the sensitivity and specicity
of each was evaluated using data from each individual ROI where an ulcer occurred,
similar to 5.3 and 5.4. The TPR and TNR are listed in tables 5.14 to 5.20. The
results show that almost each threshold can be applied with perfect sensitivity and
near-perfect specicity to the 4th MTH, with the classier 33.5 < TROI & 0 <
Tasymmetry scoring 100% sensitivity and 93.4% specicity. Similarly well-t data was
found in the 2nd Toe, but the highest sensitivity of 77.8% was was achieved by the
-2.0 < Tchange < 2.0 & -5.5 > Tbaseline with a specicity of 92.5%. The other ROIs
where ulceration occurred throughout the study cannot be spotted as easily by the
classiers. Here, the sensitivity is consistently 0%, meaning that the thresholds are
wrongly placed.
Threshold 1 Threshold 2 Sensitivity (%) Specicity (%)
33.5 < TROI 0 < Tasymmetry 0.0 91.1
33.5 < TROI 0 < Tvariance 0.0 88.3
33.5 < TROI -2.0 < Tchange < 2.0 0.0 91.7
0.5 < Tasymmetry 0.5 < Tvariance 0.0 83.9
2.0 < Tasymmetry -1.2 < Tchange < 1.2 0.0 100.0
2.0 < Tasymmetry -5 > Tbaseline 0.0 93.9
2.5 < Tvariance -0.6 < Tchange < 0.6 0.0 100.0
0.0 < Tvariance -5.5 > Tbaseline 0.0 100.0
-2.0 < Tchange < 2.0 -5.5 > Tbaseline 0.0 83.9
Table 5.14: Application of 'best' threshold values to ROIs - 1st Toe
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Threshold 1 Threshold 2 Sensitivity (%) Specicity (%)
33.5 < TROI 0 < Tasymmetry 66.7 97.7
33.5 < TROI 0 < Tvariance 66.7 95.4
33.5 < TROI -2.0 < Tchange < 2.0 66.7 97.7
0.5 < Tasymmetry 0.5 < Tvariance 33.3 97.1
2.0 < Tasymmetry -1.2 < Tchange < 1.2 0.0 100.0
2.0 < Tasymmetry -5 > Tbaseline 22.2 96.0
2.5 < Tvariance -0.6 < Tchange < 0.6 0.0 100.0
0.0 < Tvariance -5.5 > Tbaseline 0.0 100.0
-2.0 < Tchange < 2.0 -5.5 > Tbaseline 77.8 92.5
Table 5.15: Application of 'best' threshold values to ROIs - 2nd Toe
Threshold 1 Threshold 2 Sensitivity (%) Specicity (%)
33.5 < TROI 0 < Tasymmetry 0.0 96.1
33.5 < TROI 0 < Tvariance 0.0 96.1
33.5 < TROI -2.0 < Tchange < 2.0 0.0 96.1
0.5 < Tasymmetry 0.5 < Tvariance 0.0 96.1
2.0 < Tasymmetry -1.2 < Tchange < 1.2 0.0 100.0
2.0 < Tasymmetry -5 > Tbaseline 0.0 92.7
2.5 < Tvariance -0.6 < Tchange < 0.6 0.0 100.0
0.0 < Tvariance -5.5 > Tbaseline 0.0 100.0
-2.0 < Tchange < 2.0 -5.5 > Tbaseline 0.0 84.9
Table 5.16: Application of 'best' threshold values to ROIs - 3rd Toe
Threshold 1 Threshold 2 Sensitivity (%) Specicity (%)
33.5 < TROI 0 < Tasymmetry 0.0 98.9
33.5 < TROI 0 < Tvariance 0.0 99.4
33.5 < TROI -2.0 < Tchange < 2.0 0.0 98.3
0.5 < Tasymmetry 0.5 < Tvariance 0.0 98.3
2.0 < Tasymmetry -1.2 < Tchange < 1.2 0.0 100.0
2.0 < Tasymmetry -5 > Tbaseline 0.0 93.3
2.5 < Tvariance -0.6 < Tchange < 0.6 0.0 100.0
0.0 < Tvariance -5.5 > Tbaseline 0.0 100.0
-2.0 < Tchange < 2.0 -5.5 > Tbaseline 0.0 86.7
Table 5.17: Application of 'best' threshold values to ROIs - 4th Toe
Chapter 5 - Analysis 83
Threshold 1 Threshold 2 Sensitivity (%) Specicity (%)
33.5 < TROI 0 < Tasymmetry 100.0 93.4
33.5 < TROI 0 < Tvariance 100.0 89.2
33.5 < TROI -2.0 < Tchange < 2.0 100.0 91.6
0.5 < Tasymmetry 0.5 < Tvariance 100.0 86.1
2.0 < Tasymmetry -1.2 < Tchange < 1.2 0.0 100.0
2.0 < Tasymmetry -5 > Tbaseline 87.5 98.8
2.5 < Tvariance -0.6 < Tchange < 0.6 0.0 100.0
0.0 < Tvariance -5.5 > Tbaseline 6.3 100.0
-2.0 < Tchange < 2.0 -5.5 > Tbaseline 100.0 91.6
Table 5.18: Application of 'best' threshold values to ROIs - 4th MTH
Threshold 1 Threshold 2 Sensitivity (%) Specicity (%)
33.5 < TROI 0 < Tasymmetry 0.0 85.6
33.5 < TROI 0 < Tvariance 0.0 84.5
33.5 < TROI -2.0 < Tchange < 2.0 0.0 87.4
0.5 < Tasymmetry 0.5 < Tvariance 0.0 78.2
2.0 < Tasymmetry -1.2 < Tchange < 1.2 0.0 100.0
2.0 < Tasymmetry -5 > Tbaseline 0.0 90.2
2.5 < Tvariance -0.6 < Tchange < 0.6 0.0 100.0
0.0 < Tvariance -5.5 > Tbaseline 0.0 100.0
-2.0 < Tchange < 2.0 -5.5 > Tbaseline 0.0 86.2
Table 5.19: Application of 'best' threshold values to ROIs - 5th MTH
Threshold 1 Threshold 2 Sensitivity (%) Specicity (%)
33.5 < TROI 0 < Tasymmetry 0.0 97.2
33.5 < TROI 0 < Tvariance 0.0 96.1
33.5 < TROI -2.0 < Tchange < 2.0 0.0 98.3
0.5 < Tasymmetry 0.5 < Tvariance 0.0 87.7
2.0 < Tasymmetry -1.2 < Tchange < 1.2 0.0 100.0
2.0 < Tasymmetry -5 > Tbaseline 0.0 98.9
2.5 < Tvariance -0.6 < Tchange < 0.6 0.0 100.0
0.0 < Tvariance -5.5 > Tbaseline 0.0 100.0
-2.0 < Tchange < 2.0 -5.5 > Tbaseline 0.0 99.4
Table 5.20: Application of 'best' threshold values to ROIs - 5th MTH Base
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This becomes apparent when one looks at the graphing for these parameters, a sample
of which are in gures 5.16 to 5.22. The full set of graphs are shown in appendix C.
In gures 5.16, 5.18, 5.19 and 5.22 the amount of ulceration cohort data is too low
for analysis (2-3 data points) however they do show signs that the separation of the
data points is not as easy as a simple threshold. On the other hand, gures 5.17 and
5.20 reect the improved classier results in table 5.15 and 5.18. Here the ulceration
data can be separated from non-ulcerated points by a threshold value with few false
positive and false negative results.
Figure 5.16: ROI temperature vs temperature asymmetry 1st toe plot
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Figure 5.17: ROI temperature vs temperature asymmetry 2nd toe plot
Figure 5.18: ROI temperature vs temperature asymmetry 3rd toe plot
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Figure 5.19: ROI temperature vs temperature asymmetry 4th toe plot
Figure 5.20: ROI temperature vs temperature asymmetry 4th MTH plot
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Figure 5.21: ROI temperature vs temperature asymmetry 5th MTH plot
Figure 5.22: ROI temperature vs temperature asymmetry 5th MTH Base plot
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5.4 Summary
In summary, three methods were used to evaluate ve parameters by thresholds. In
the rst method the current "gold standard" classier was evaluated with various
thresholds against the data gathered in this project. The evaluation showed that
this method is not very reliable and achieves sensitivity and specicity values be-
tween 40-44% and 80-82%, respectively. The second method attempted to combine
two threshold methods into a classier for all data points. These classiers showed
improved results with sensitivity and specicity values between 50-53% and 90-95%,
respectively. The third method that was attempted was splitting the data into the
12 ROIs assigned in chapter 4 (Figure 4.1) and apply the most promising classiers
that were dened in the second method. This method showed to be the most ef-
fective method for the 2nd toe and 4th MTH, where the sensitivity and specicity
values increased greatly. In most of the classiers for the 4th MTH, the sensitivity
is 100% and the specicity is above 90%. However, this is based on the ulceration
cohort data of a single person only. Consequently, when applied to the remaining
ve ROIs, the sensitivity drops to 0%.
Even though it has been shown that splitting the data into ROIs before analysis can
increase the sensitivity and specicity to predict an ulcer, the data set suers from
the lack of positive outcomes, the low measurement frequency and the inaccuracy
of the infrared camera. The small sample size of positive outcomes in this study
of 26 (excluding behavioural ulcers) is not sucient to draw denitive conclusions
about how an ulcer could be predicted using only temperature measurements. This
problem is amplied by the low measurement frequency of, on average, one month.
Futhermore, the inaccuracy of the camera allows for a temperature variation of
±0.2 ◦C (after calibration by NPL). In addition, the temperature is varied by another
±0.24 ◦C (two standard deviations) by the warping process (see section 2.5.5). These
three factors combined reduce the believability of the threshold values but on the
other hand may provide an explanation as to why the data is spread out in some of
the presented graphs.
The spread of the data in graphs such as gure 5.21 may be explained by the fre-
quency of measurements. If a shorter interval between measurements such as daily
as used in [12] were used, the increase in data would allow for a complete history
of the development of an ulcer and a an increase in the believability of the stated
classiers.
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In comparison to what is currently the 'gold standard', this data set does not reect
an accurate classier, with the highest sensitivity that could be achieved reaching
39.5 % while maintaining a specicity of at least 90 % using 2.0 < abs(Tasymmetry).
This is a similar threshold that was previously used by Frykberg [12] and Van Netten
[8]. The values found for the sensitivity and specicity are similar but cannot be
directly compared to Frykberg because the time element is missing. When applying
a time constraint to the data the sensitivity drops below 2 %, but even this is not a
100 % compatible classier (Table 5.21).
In conclusion, the likelihood of the explored classiers being a realistic predictor of
foot ulceration is low due to the combination of small ulceration cohort number, low
measurement frequency and camera inaccuracy.
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Threshold TPR (%) TNR (%) PPV (%) NPV (%)
0.1 0.8 70.0 16.7 8.5
0.2 0.9 81.1 16.7 15.7
0.3 0.7 84.7 13.0 21.2
0.4 0.8 87.8 13.0 27.5
0.5 0.6 89.4 9.3 33.7
0.6 0.7 90.9 9.3 39.7
0.7 0.7 91.6 9.3 43.6
0.8 0.8 92.4 9.3 48.5
0.9 0.7 92.8 7.4 52.5
1.0 0.7 93.3 7.4 56.4
1.1 0.6 93.5 5.6 59.6
1.2 0.7 93.8 5.6 62.9
1.3 0.7 94.1 5.6 66.2
1.4 0.5 94.2 3.7 68.8
1.5 0.5 94.3 3.7 70.6
1.6 0.6 94.5 3.7 73.1
1.7 0.6 94.7 3.7 75.1
1.8 0.7 94.8 3.7 77.0
1.9 0.8 94.9 3.7 78.9
2.0 0.8 95.0 3.7 80.8
2.1 0.9 95.1 3.7 81.9
2.2 0.9 95.1 3.7 82.8
2.3 1.0 95.2 3.7 84.1
2.4 1.1 95.3 3.7 85.1
2.5 1.1 95.3 3.7 86.0
2.6 1.2 95.4 3.7 86.7
2.7 1.3 95.4 3.7 87.8
2.8 1.4 95.5 3.7 88.8
2.9 1.5 95.5 3.7 89.1
3.0 1.6 95.5 3.7 89.7
3.1 1.6 95.5 3.7 90.1
3.2 1.7 95.5 3.7 90.7
3.3 1.9 95.6 3.7 91.5
3.4 1.9 95.6 3.7 91.8
3.5 2.2 95.6 3.7 92.8
Table 5.21: Statistical values for various ROI temperature dierence thresholds
- taking into account time
Chapter 6
Next Generation Device
The performance of the rst generation device was assessed throughout the trials
by feedback from the clinical centres and updated to suit the needs of the centres.
The device itself was characterised by the NPL at the start, once in between and
nally again at the end of both trials. It was also compared to the current gold
standard spot measurement device during the rst trial [41]. The characterisation
and comparison showed the device to be suitable for imaging the foot and analysis,
satisfying all clinical requirements in full.
Based on the experience gained the next generation of this device is already in
development and utilises the well known Raspberry Pi cameras. With new technology
emerging around smaller and cheaper infrared cameras, the FLIR Lepton Version 3
(160x120 pixels) was chosen as the infrared sensor for the successor to the DFUPS
device to cut cost, size and weight. The device is equipped with two Raspberry Pi
computers, two cameras for stereovision, a ash mechanism consisting of four power
LEDs, a speaker and fans for cooling. The device incorporates the same 'targeting'
system as the DFUPS device (briey mentioned in section 3.2.1) to take images
from the correct distance with the addition of a method to adjust the height of the
projected dots.
The FLIR Lepton sensor was calibrated with the help of the NPL and control software
written by the author. Figures 6.1a and 6.1b show the calibration setup at the
NPL. Calibration is necessary as the FLIR Lepton comes equipped only with default
factory values for calibration which do not account for the variations present in each
individual sensor. However it is possible to read out raw sensor data, from which an
individual calibration can be created. In the background of gure 6.1b, 4 blackbody
reference devices are shown against which the sensor was tested.
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(a) FLIR Lepton calibration
(back view) setup
(b) FLIR Lepton calibration
(front view) setup
Figure 6.1: FLIR Lepton calibration setup
The process of calibration was carried out using several dierent blackbody reference
devices. These included:
1. Ammonia (NH3) - temperature range from -40 to 40 ◦C
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2. Thermal Imaging BlackBody (TIBB) - temperature range from 10 to 80 ◦C
The rst step of the calibration was to gather data from the sensor. It was carried
out in multiple runs at varying temperatures from the blackbody reference device at
a set distance of 30 cm. For each run, the blackbody reference device was set to the
desired temperature and after reaching the set point, a further 10 minute delay was
added to make sure the temperature was stable. This was cross-referenced using a
PRT. The Lepton sensor was then aligned with the device at a specic distance and
12 images were taken in series to establish repeatability. A note was made of the
temperature measured by the PRT for every image. A total of 11 runs were done on
the NH3 device and 21 on the TIBB device. The ambient temperature was kept as
close as possible to 21 ◦C.
A second calibration was attempted by moving the Lepton along a predened grid
to attain dierent angles to the measurement source. This proved to be dicult to
analyse in later processing.
The second step of the calibration consists of a computer vision approach to segment-
ing the images into black body cavity and background. This was accomplished using
a series of standard computer vision techniques available in the open source OpenCV
library network and a custom algorithm written by the author. An example is shown
in gure 6.2. The input image (gure 6.2a) is rst passed through a Gaussian l-
ter followed by a Canny edge detector with the default OpenCV parameters. From
the resultant edge image, the contours are extracted using OpenCV's ndContours
function. This leaves only outlines of shapes (gure 6.2b). From there, an attempt
is made to nd the largest area circle without touching any contour starting from
the center of the image, which is assumed to be the center of blackbody reference
device. This is done by dening a circle with a radius of 0 pixels at the center of the
image and incrementing the radius until a boundary (white pixel) is encountered on
the edge of the circle. When this happens, the centroid of all intersections to the
boundary is calculated and the center of the circle is moved by 1 pixel in the opposite
direction of the intersections. This corrects for non-perfect alignment between the
sensor and the device, which was done visually only. The two steps of enlarging the
circle and moving the center of the circle is repeated until the center of the circle
returns to a position in which it has already been. The radius is then multiplied by
2
3 to ensure that the edges of the circle, which may have a slightly dierent temper-
ature, are not taken into account. An example of the completed algorithm is shown
in 6.2c.
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The same process is shown in gure 6.3, but this time with a temperature of 15 ◦C
set on the blackbody reference device. In gure 6.3b, some additional edges are seen
that should be interpreted as noise. Most of these contours are ignored (gure 6.3c),
but there is another contour within the target area which limits the detected area.
(a) Step 1 (b) Step 2 (c) Step 3
Figure 6.2: FLIR Lepton software extraction 15 ◦C example
(a) Step 1 (b) Step 2 (c) Step 3
Figure 6.3: FLIR Lepton software extraction 45 ◦C example
The extracted data was then graphed and analysed by the NPL. The results show
that is advantageous to stabilise the Focal Plane Array (FPA) temperature as best
as possible to ensure a consistent temperature readout. This is demonstrated by
gures 6.4a and 6.4b. There was no conclusive relationship between the signal value,
FPA temperature and radiant temperature.














































































Figure 6.4: Lepton calibration data graphing
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The other aspect of the next generation device is the software, written by the au-
thor. The user interface is based on the software of the DFUPS device, with minor
variations. Figures 6.5 and 6.6 show screenshots of various parts of the software.
These are comparable to gure 3.6a. In the second version of the software, the xed
image series restriction is lifted because the next generation device is meant to be
a generic imaging device. The addition of icons serves the purpose of making the
interface smaller in addition to maintaining a clear message for each button.
20 of these devices have been built and sold to the NPL in its current stage of devel-
opment. Negotiations are under way for the mass production of these devices. Cur-
rently, there is a student continuing work on the user interface and a PhD candidate
at the University of South Wales working on improving the 3D image generation al-
gorithms. These improvements will hopefully allow the integration of more advanced
algorithms for point cloud processing and enable automated data extraction.
Future versions will combine the electronics into one printed circuit board to enable
mass manufacturing. Moreover, elements for heating and cooling need to be added to
allow for the stabilisation of the thermal camera as well as software to control them.
This thought can be extended to the visual camera, where an improved method
of securing the cameras will result in a less noisier input image to the algorithm
responsible for calculating the 3D images.
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(a) Capture screen showing lepton sensor output
(b) Capture screen showing raspberry pi camera output
Figure 6.5: Software version 2 screenshots
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(a) Settings screen
(b) Download screen
Figure 6.6: Software version 2 screenshots - continued
Chapter 7
Conclusion
7.1 Achievement of Objectives
The following section summarises the objectives of this thesis in regards to the re-
search question and discusses how well they were achieved. The specic objectives,
originally set in section 1.4, are:
1. Research into the underlying physical principles of infrared imaging, detector
technologies and their respective spatial and thermal resolutions, and error
sources associated with both technology and usage in clinical practice.
2. Development of hardware and software for a device capable of addressing the
aim in a clinically feasible manner.
3. Implementation of the device and provision to the 3 clinical centres associated
with this project.
4. Implementation of a Website capable of mass manual image object outlining.
5. Analysis of the data collected by the clinical centres with the aim of:
 Establishing and verifying a methodology for data extraction and group-
ing
 Conrming/rejecting the currently accepted 2.2 ◦C threshold
 Finding an improved method over the 2.2 ◦C threshold
The extent to which these objectives were met is now discussed in the following
sections 7.1.1 to 7.1.5.
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7.1.1 Research into the Underlying Physical Principles of Infrared
Imaging
Research into the physical principles is primarily documented in the background
research chapter of this thesis. Principal knowledge for infrared imaging was ac-
quired about the dierent types of infrared radiation and common detector types.
This knowledge allowed for the correct choice of infrared imager for the project and
appropriate measures to control environmental variables. The o-the-shelf thermal
camera that was used is similar to those used for thermography in biomedicine. The
factory accuracy of the thermal imager is ±2 % of the temperature value or ±2 ◦C,
whichever is greater. This was corrected using characterisation data provided by the
NPL, thus allowing for above-average quality measurements to take place. Instead
of the original ±2 % accuracy the author's software corrected the thermal data to
within ±0.2 ◦C.
7.1.2 Development of the Infrared Imaging Device
The development of the preliminary hard- and software for this project had to be
achieved within a time span of 3 months in order to stay in the project time plan
and to allow clinicians sucient time to complete two clinical trials. Throughout
the following two years of usage, several minor shortcomings were discovered in
the device. None of these shortcomings jeopardised the project at any moment in
time. Software issues could be dealt with swiftly but issues with the hardware were
persistent. For example, the USB bus of the Odroid-U3 was not able to support two
cameras as expected, which would have allowed for stereoscopic vision and thus a
3D image with which control points could have been placed automatically onto the
images. This called for an extra step in the process of analysis to take place, namely
the use of a website designed and implemented by the author to be able to complete
the task of outlining feet on hundreds of images by 14 volunteers (see 7.1.4 below).
Similar devices have been constructed in the past but have not been used extensively
in a clinical context [42, 43, 44]. Devices that are used in a clinical setting tend to be
rigid and bulky such as the system used in [8]. Additionally, the device conceptualised
in this project is approved as a medical device (for the purpose of this particular
clinical investigation, not for general use or sale) and has been tested in multiple
clinical centres with positive feedback. Its small footprint combined with the modern
imaging capability proved to be a successful design.
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7.1.3 Implementation of the Device
The implementation of the device was fullled adequately for the two trials. The
hardware was assembled according to the plans created in the previous objective.
However, in some devices, the camera responsible for capturing the visible spectrum
came loose during operation and captured images with a large oset with respect to
the infrared image. This was, however, not a concern as the visual images were not
used during analysis for automatic segmentation.
The software for the device was created by the author in Qt and C++ and contin-
uously revised during the project utilising feedback from the clinical centres. It is a
graphical user interface and similar to a generic imaging device but includes options
dedicated to this project such as the device forcing a series of images to be taken
with correct labelling according to the specication of the clinical trial protocol. To
the best of the author's knowledge such a software driven protocol implementation
has never been attempted before but it proved to be highly successful. Virtually
all image data could be used in the analysis with no data set being invalid due to
wrong timings, views, order or other typical user mistakes. Some issues surrounding
the operating system and software occasionally stopped a device from working alto-
gether. However, these incidents were small in number and could usually be resolved
by turning the device o and on again.
7.1.4 Implementation of Website for Mass Manual Image Object
Outlining
The implementation of a website for outlining was successfully completed. The main
aspect of this objective was to increase the speed which was fullled as it took the
participating volunteers only two weeks after the launch of the website to complete
1361 plantar images (7.7% of all images, including unused and unusable) outlines.
However, even though there were measures in place to stop erroneous placement of
control points and correcting the order in which the points were placed, approx. 500
images needed reworking. In addition, the website required some maintenance for
the database that stored the images and kept track of what was being done. The
outcome was, however, very successful as it would have taken one person several
weeks to outline all images, even when taking into account the reworking of images.
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7.1.5 Analysis of the Data Collected by the Clinical Centres
The analysis of the collected data was completed using three distinct methods and
ve input parameters using 12 measurement spots. Although each method shows
potential to spot an ulceration site, emphasis should be put into dividing the foot
into regions of interest that are analysed individually. This has not been done be-
fore to the best knowledge of the author. This particularly applies to areas where
lower temperatures resulted in ulceration. The author's analysis shows that it may
be possible to predict the onset of foot ulceration using a variety of dierent meth-
ods. However, at the same time three limitations combine to drastically lower the
likelihood of this being a realistic method.
The current gold standard 2.2 ◦C temperature asymmetry threshold was assessed
using the collected data and found to be not suitable for the task of predicting the
onset of foot ulceration when using a measurement interval of four weeks only. Using
instead the threshold of 33.5 ◦C < TROI increased the sensitivity and specicity that
the gold standard produces. This sensitivity and specicity can be further increased
using a combination of 33.5 ◦C < TROI and 0 < Tasymmetry.
7.2 Contribution to Knowledge
The contributions to knowledge that arose from this project are:





These are detailed in the following sections 7.2.1 to 7.2.5.
7.2.1 Journal and conference contributions
The author has successfully published a paper on the 'Segmentation of Infrared Im-
ages Using Stereophotogrammetry' [45] and contributed to two papers that emerged
from this project (see appendix D for certicates of contribution):
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1. A medical thermal imaging device for the prevention of diabetic foot ulceration
- Physiological measurement (2017)
2. Thermal symmetry of healthy feet: a precursor to a thermal study of diabetic
feet prior to skin breakdown - IOPScience (2016)
as well as 5 conferences in the eld of thermography and medicine:
1. European Association of Thermography, Madrid, September 2015
2. Medical Infrared Thermography, London, April 2016
3. European Association of Thermography, Gdansk, July 2016
4. European Association of Thermography, Zakopane, April 2017
5. European Congress on Computational Methods in Applied Sciences and Engi-
neering, Porto, October 2017
6. Congress on Thermology in Medicine: Clinical Thermometry and Thermal
Imaging, London 2018
7.2.2 Hardware
Over the course of this project a device which integrates a thermal camera, an em-
bedded computing device and a 3D stereophotogrammetric camera system and touch
screen technology in a novel and up-to then non-existing manner was developed. It
enabled research into the mass adoption of thermal imaging devices in a clinical
setting and the necessary steps into mass analysis of thermal images. Moreover, it
allowed to assess the necessity of a thermal imaging device in the context of diabetic
foot ulceration. Although this has already been done in the past it has not been
done on this project's scale.
The second generation device is currently being developed on the basis of a Rasp-
berry Pi to overcome the shortcomings of the rst generation. It features two visual
cameras and a FLIR Lepton sensor for data acquisition. This allows it to have
a smaller footprint than the rst device and enables novel integrated 3D thermal
imaging.
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7.2.3 Software
The software aspect of this project is split into two parts: The device software and
algorithmic developments.
The device software is comprised of a new specialised user guidance concept with
error resilience and various hardware technologies integrated into a single unit. An-
other innovation is the user interface for the device which was tailored to the clinical
protocol's demands such as the order of taking images and saving the data into a
structure that combines all images into one le. New insights into user guidance,
error resiliance (e.g. automated recovery, detection of improbable device states and
imaging results), and the integration of the various hardware technologies into a sin-
gle unit have been gained. The methodology of guiding the user through the process
of entering basic patient information and identiers and then going through a specic
order of imaging was adapted from the clinical protocol.
The novel algorithmic developments that arose from this project are the use of
barycentric coordinates in combination with cubic splines to allow smooth outlines
to be warped into a standardised shape. This algorithm is aimed at image data
in which segmentation is dicult to achieve using standard methods of computer
vision. This algorithm was integrated into a tool set written by the author; capable
of automatic data point extraction and processing. An error analysis was performed
to assess its performance (2.5.4).
7.2.4 Methodologies
Several novel methods were developed for the various aspects of the project. These
were:
1. Data collection protocol developed in collaboration with the project's clinical
partners (section 3.1)
2. Contributions to FLIR Lepton calibration procedure in collaboration with the
NPL (chapter 6)
3. Analysis methodologies (section 3.3 and chapter 5)
4. Method for simultaneous drawing of boundaries by volunteers (section 3.3)
Each of these methodologies is novel and unique to the best of the author's knowledge.
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7.2.5 Analysis
The analysis of the data was completed using previously unexplored input param-
eters in an attempt to nd a suitable classier or combination of classiers for the
prediction of foot ulceration. These include the use of the temperature variance, dif-
ference over time and the dierence to a baseline. Moreover, the data was separated
into 12 regions of interest that were analysed individually.
It was found that the currently accepted threshold (abs(Tasymmetry) <2.2
◦C) is cor-
rect but is not a good qualier on its own. Using combinations of input param-
eter thresholds showed an improvement in the results. In particular the use of
TROI >33.5
◦C and abs(Tchangeovertime) <2
◦C increased the sensitivity and speci-
city with respect to the gold standard by 11% and 14%, respectively.
7.3 Achievement of Aim
The aim of predicting diabetic foot ulceration with the aid of infrared imaging has
been reached partially. The analysed methods and parameters hint towards it being
possible to predict ulceration. The results are, however, not conclusive due to two
reasons. The rst reason is the relatively long period of time between measurements
of about four weeks, where other researchers have measured daily and claim a lead
time of approximately 30 days when three consecutive measurements are outside the
accepted tolerance [12]. The second reason is the amount of data points available for
analysis. 12 ulcers were registered during the second trial period (11 usable) and a
total of 52 data points could be extracted. This number is too low to allow conclusive
results. The hypothesis can therefore neither be accepted nor rejected.
7.4 Future Work
The data presented in this project shows the potential for predicting ulceration with
increased accuracy and the creation of complex devices with low-cost hardware. In
light of the results from this project, a new company was founded by some of the
project collaborators with the aim of developing a low-cost home monitoring system
which users can use daily. The results presented in this thesis are informing the
development process of this device. A second device for clinical use, complementary
to the home use system and close to the one presented in this work is also under
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development. Both the home use and clinical device are likely to open up the possi-
bility for exploring the methods and techniques presented in this work in more depth
than is currently possible.
Appendix A
Appendix - Data plots
Figure A.1: ROI temperature plot - 1st Toe
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Figure A.2: ROI temperature plot - 2nd Toe
Figure A.3: ROI temperature plot - 3rd Toe
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Figure A.4: ROI temperature plot - 4th Toe
Figure A.5: ROI temperature plot - 4th MTH
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Figure A.6: ROI temperature plot - 5th MTH
Figure A.7: ROI temperature plot - 5th MTH Base
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Figure A.8: Temperature asymmetry plot - 1st Toe
Figure A.9: Temperature asymmetry plot - 2nd Toe
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Figure A.10: Temperature asymmetry plot - 3rd Toe
Figure A.11: Temperature asymmetry plot - 4th Toe
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Figure A.12: Temperature asymmetry plot - 4th MTH
Figure A.13: Temperature asymmetry plot - 5th MTH
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Figure A.14: Temperature asymmetry plot - 5th MTH Base
Figure A.15: Temperature variance plot - 1st Toe
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Figure A.16: Temperature variance plot - 2nd Toe
Figure A.17: Temperature variance plot - 3rd Toe
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Figure A.18: Temperature variance plot - 4th MTH
Figure A.19: Temperature variance plot - 5th MTH
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Figure A.20: Temperature variance plot - 5th MTH Base
Figure A.21: Temperature change over time - 1st Toe
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Figure A.22: Temperature change over time - 2nd Toe
Figure A.23: Temperature change over time - 3rd Toe
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Figure A.24: Temperature change over time - 4th MTH
Figure A.25: Temperature change over time - 5th MTH
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Figure A.26: Temperature change over time - 5th MTH Base
Figure A.27: Dierence to baseline - 1st Toe
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Figure A.28: Dierence to baseline - 2nd Toe
Figure A.29: Dierence to baseline - 3rd Toe
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Figure A.30: Dierence to baseline - 4th MTH
Figure A.31: Dierence to baseline - 5th MTH
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Figure A.32: Dierence to baseline - 5th MTH Base
Appendix B
Appendix - Receiver Operater
Curves using one Dimension
Figure B.1: ROI temperature ROC - 1st Toe
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Figure B.2: ROI temperature ROC - 2nd Toe
Figure B.3: ROI temperature ROC - 3rd Toe
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Figure B.4: ROI temperature ROC - 4th Toe
Figure B.5: ROI temperature ROC - 4th MTH
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Figure B.6: ROI temperature ROC - 5th MTH
Figure B.7: ROI temperature ROC - 5th MTH Base
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Figure B.8: Temperature asymmetry ROC - 1st Toe
Figure B.9: Temperature asymmetry, ROC - 2nd Toe
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Figure B.10: Temperature asymmetry, ROC - 3rd Toe
Figure B.11: Temperature asymmetry, ROC - 4th Toe
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Figure B.12: Temperature asymmetry, ROC - 4th MTH
Figure B.13: Temperature asymmetry, ROC - 5th MTH
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Figure B.14: Temperature asymmetry, ROC - 5th MTH Base
Figure B.15: Temperature variance ROC - 1st Toe
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Figure B.16: Temperature variance ROC - 2nd Toe
Figure B.17: Temperature variance ROC - 3rd Toe
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Figure B.18: Temperature variance ROC - 4th Toe
Figure B.19: Temperature variance ROC - 4th MTH
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Figure B.20: Temperature variance ROC - 5th MTH
Figure B.21: Temperature variance ROC - 5th MTH Base
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Figure B.22: Temperature change over time ROC - 1st Toe
Figure B.23: Temperature change over time ROC - 2nd Toe
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Figure B.24: Temperature change over time ROC - 3rd Toe
Figure B.25: Temperature change over time ROC - 4th Toe
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Figure B.26: Temperature change over time ROC - 4th MTH
Figure B.27: ROI temperature vs Mean ROCs
Figure B.28: Temperature change over time ROC - 5th MTH
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Figure B.29: Temperature change over time ROC - 5th MTH Base
Figure B.30: Dierence to baseline ROC - 1st Toe
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Figure B.31: Dierence to baseline ROC - 2nd Toe
Figure B.32: Dierence to baseline ROC - 3rd Toe
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Figure B.33: Dierence to baseline ROC - 4th Toe
Figure B.34: Dierence to baseline ROC - 4th MTH
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Figure B.35: Dierence to baseline ROC - 5th MTH
Figure B.36: Dierence to baseline ROC - 5th MTH Base
Appendix C
Appendix - Applying Thresholds
to ROIs
Figure C.1: ROI temperature vs temperature variance 1st toe plot
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Figure C.2: ROI temperature vs temperature variance 2nd toe plot
Figure C.3: ROI temperature vs temperature variance 3rd toe plot
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Figure C.4: ROI temperature vs temperature variance 4th toe plot
Figure C.5: ROI temperature vs temperature variance 4th MTH plot
Appendix C - Applying Thresholds to ROIs 145
Figure C.6: ROI temperature vs temperature variance 5th MTH plot
Figure C.7: ROI temperature vs temperature variance 5th MTH Base plot
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Figure C.8: ROI temperature vs temperature change over time 1st toe plot
Figure C.9: ROI temperature vs temperature change over time 2nd toe plot
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Figure C.10: ROI temperature vs temperature change over time 3rd toe plot
Figure C.11: ROI temperature vs temperature change over time 4th toe plot
Appendix C - Applying Thresholds to ROIs 148
Figure C.12: ROI temperature vs temperature change over time 4th MTH plot
Figure C.13: ROI temperature vs temperature change over time 5th MTH plot
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Figure C.14: ROI temperature vs temperature change over time 5th MTH Base
plot
Figure C.15: temperature asymmetry vs temperature variance 1st toe plot
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Figure C.16: temperature asymmetry vs temperature variance 2nd toe plot
Figure C.17: temperature asymmetry vs temperature variance 3rd toe plot
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Figure C.18: temperature asymmetry vs temperature variance 4th toe plot
Figure C.19: temperature asymmetry vs temperature variance 4th MTH plot
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Figure C.20: temperature asymmetry vs temperature variance 5th MTH plot
Figure C.21: temperature asymmetry vs temperature variance 5th MTH Base
plot
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Figure C.22: temperature asymmetry vs temperature change over time 1st toe
plot
Figure C.23: temperature asymmetry vs temperature change over time 2nd toe
plot
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Figure C.24: temperature asymmetry vs temperature change over time 3rd toe
plot
Figure C.25: temperature asymmetry vs temperature change over time 4th toe
plot
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Figure C.26: temperature asymmetry vs temperature change over time 4th MTH
plot
Figure C.27: temperature asymmetry vs temperature change over time 5th MTH
plot
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Figure C.28: temperature asymmetry vs temperature change over time 5th MTH
Base plot
Figure C.29: temperature asymmetry vs dierence to baseline 1st toe plot
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Figure C.30: temperature asymmetry vs dierence to baseline 2nd toe plot
Figure C.31: temperature asymmetry vs dierence to baseline 3rd toe plot
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Figure C.32: temperature asymmetry vs dierence to baseline 4th toe plot
Figure C.33: temperature asymmetry vs dierence to baseline 4th MTH plot
Appendix C - Applying Thresholds to ROIs 159
Figure C.34: temperature asymmetry vs dierence to baseline 5th MTH plot
Figure C.35: temperature asymmetry vs dierence to baseline 5th MTH Base
plot
Appendix C - Applying Thresholds to ROIs 160
Figure C.36: temperature variance vs temperature change over time 1st toe plot
Figure C.37: temperature variance vs temperature change over time 2nd toe plot
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Figure C.38: temperature variance vs temperature change over time 3rd toe plot
Figure C.39: temperature variance vs temperature change over time 4th toe plot
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Figure C.40: temperature variance vs temperature change over time 4th MTH
plot
Figure C.41: temperature variance vs temperature change over time 5th MTH
plot
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Figure C.42: temperature variance vs temperature change over time 5th MTH
Base plot
Figure C.43: temperature variance vs dierence to baseline 1st toe plot
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Figure C.44: temperature variance vs dierence to baseline 2nd toe plot
Figure C.45: temperature variance vs dierence to baseline 3rd toe plot
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Figure C.46: temperature variance vs dierence to baseline 4th toe plot
Figure C.47: temperature variance vs dierence to baseline 4th MTH plot
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Figure C.48: temperature variance vs dierence to baseline 5th MTH plot
Figure C.49: temperature variance vs dierence to baseline 5th MTH Base plot
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Figure C.50: temperature change over time vs dierence to baseline 1st toe plot
Figure C.51: temperature change over time vs dierence to baseline 2nd toe plot
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Figure C.52: temperature change over time vs dierence to baseline 3rd toe plot
Figure C.53: temperature change over time vs dierence to baseline 4th toe plot
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Figure C.54: temperature change over time vs dierence to baseline 4th MTH
plot
Figure C.55: temperature change over time vs dierence to baseline 5th MTH
plot
Appendix C - Applying Thresholds to ROIs 170
Figure C.56: temperature change over time vs dierence to baseline 5th MTH
Base plot
Appendix D
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Clinical study protocol version 1 (23 July 2014) pg. 1 
Protocol title: i4i NIHR An Innovative System for the Early 
Identification, Monitoring, Evaluation and Diagnosis of Diabetic 
Foot Ulcers 
1.1 Trial Identifiers 
REC Number –  
1.2 Sponsor 
Name: King’s College Hospital NHS Foundation Trust  
Address: Denmark Hill, London SE5 9RS, UK 
 
1.2.1 Sponsor Contact 
Dr Zoe Harris, Manager R&D 
The Research Office 
King’s College Hospital NHS Foundation Trust  
161 Denmark Hill 
SE5 8EF 
Telephone:  020 7188 3841 
Email:  z.harris@nhs.net 
 
1.2.2 Chief Investigator  
Name: Dr Michael Edmonds, Professor of Diabetic Foot Medicine 
Address: Diabetic Foot Clinic, King’s College Hospital, Denmark Hill, London, SE5 9RS 
Telephone: 0203 299 3223 
Fax: 0203 299 4536 
Email: Michael.edmonds@nhs.net 
 
1.2.3 Name and address of Co-Investigator(s), Statistician, Laboratories etc 
Name: Dr Nina Petrova,  
Address: Diabetic Foot Clinic, King’s College Hospital, Denmark Hill, London, SE5 9RS 
Telephone: 0203 299 5124 
Fax: 0203 299 4536 
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Email: nina.petrova@nhs.net 
 
Dr Nora Donaldson, Professor of Biostatistics 
Address: Biostatistics Unit, KCL Dental Institute Denmark Hill Campus.  
Dental Surgery Building. Office 209 
Telephone: 020 32901654 
Email: Nora.Donaldson@kcl.ac.uk 
 
Name: Professor Graham Machin, Head, Temperature Standards, NPL Fellow  
Address: National Physical Laboratory,  
Temperature Group, Hampton Road 
Teddington, Middlesex, United Kingdom  
Post Code TW11 0LW 
Phone number +44 0208 943 6742 
Email graham.machin@npl.co.uk 
 
Name: Dr Robert Simpson 
Address: National Physical Laboratory,  
Temperature Group, Hampton Road 
Teddington, Middlesex, United Kingdom  
Post Code TW11 0LW 
 
Name: Dr Leon Rogers 
Address: National Physical Laboratory,  
Temperature Group, Hampton Road 
Teddington, Middlesex, United Kingdom  
Post Code TW11 0LW 
 
Name: Aaron Whittam 
Address: National Physical Laboratory,  
Temperature Group, Hampton Road 
Teddington, Middlesex, United Kingdom  
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Post Code TW11 0LW 
 
Name: Dr John Bevans 
Address: 
 
Name: Dr John Allen 
Address: 
 
Name: Professor Francis Ring 
Address: 
 
Name: Dr Peter Plassmann 
Address: 
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1.3 Background & Rationale 
The global burden of diabetes is well recognised. At present, it is estimated that 382 million 
people have diabetes and by 2035 it is predicted that diabetes will affect 592 million people 
(http://www.idf.org/diabetesatlas/introduction). Diabetic neuropathy (nerve damage to the feet) is 
a common complication of diabetes. The lack of pain and the loss of protective sensation to the 
feet of people with diabetes puts them at risk of foot ulceration. These ulcers can become 
infected, seriously affect the patient’s quality of life and increase the risk of amputation. Diabetic 
foot ulcer management requires significant resources. Early recognition of foot ulceration and 
timely management is critical to avoid adverse outcomes.  
 
Current guidelines recommend the early identification of risk, based on foot screening and 
targeting of preventative interventions to ‘high-risk’ individuals. Prior to breakdown of the skin, at 
the start of an ulcer, an inflammatory state is developed which is characterised by a rise in local 
skin temperature
i
. The areas at risk may present with redness, thickness, warmth and swelling. 
Thermal imaging can be a valuable technology in the prevention and early identification of 
diabetic foot ulceration as it can detect areas at risk prior skin breakdown. Recently, the potential 
therapeutic benefit of temperature monitoring with single spot infra-red thermometry has been 
evaluated in a randomized controlled trial. A high-risk group of patients with previous history of 
neuropathic ulceration were randomised to either self-skin temperature monitoring and standard 
care or to standard care alone. There was a significant reduction in the ulcer reoccurrence rate in 
the active group compared with the control group (8% in the active group versus 30% in the 
control group, p<0.05) 
ii
. The patients in the control group were more than 4 times more likely to 
develop ulcers compared with patients in the active group during a 15 month follow up 
ii
.  
Although its potential benefit, thermal imaging has not yet become a widely used method in 
clinical practice. At present, mainly single spot thermometers are used in clinical practice, which 
measure temperature only above the scanned area and do not provide information of the 
surrounding areas. Furthermore, an incipient lesion may also be characterised by a rise of skin 
foot temperature but is not obviously visible on clinical examination. Therefore, a thermal image of 
the feet will allow full examination and early detection of areas at risk.   
 
It is now possible with recent advances in thermal imaging and image analysis to produce a low-
cost clinical device that can generate temperature maps of the patient’s feet. These maps can be 
used by clinicians to identify areas at risk of ulceration, presenting with a temperature rise.  
 
Recently, a new non-invasive infrared thermal camera has been developed (diabetic foot ulcer 
prevention system (DFUPS). Thermal imaging of a small sample of feet in healthy subjects has 
been carried out with this instrument under laboratory condition to assess the following 
specification requirements: temperature range/resolution, required spatial resolution and 
performance (stability/accuracy). Early data has shown that this instrument is robust, easy to use 
and can record repeatable measurements. 
 
We propose to evaluate this instrument in a clinical setting by studying healthy volunteers.  
 
1.4 Trial Objectives and Design  
1.4.1 Trial Objectives 
The main objectives are: 
 
 To evaluate the usefulness of DFUPS  in a clinical setting 
 
 To iterate the design of the instrument.  
 
In particular, the aim is to detect detailed temperature readings of the feet of healthy volunteers 
and to analyse temperature distribution by creating temperature maps. This novel instrument will 
be compared with “gold standard” single spot thermometry (Dermatemp 1001, Exergen).  
A detailed skin foot temperature measurement protocol will be developed which can be translated 
into clinical practice and used in the assessment of diabetic patients at risk of foot ulceration.  
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1.4.2 Trial design 
This is a multicentre centre study of healthy volunteers who will be recruited at 3 clinical sites.  
 
1. Diabetic Foot Clinic, Kings College Hospital NHS Foundation Trust 
2. Department of …. ; Freeman Hospital, Newcastle upon Tyne 
3. Department of …….North Manchester General Hospital  
 
The study will involve skin foot temperature measurements with the proposed prototype (DFUPS) 
and the current gold standard thermometry Dermatemp 1001 in a group of 100 healthy 
volunteers.  
 
1.5 Selection of participants:  
Members of staff, relatives and friends will be invited to take part in the study. A letter/email of 
invitation will be sent. There will be also a poster in the clinic waiting area and eligible participants 
will be also invited.   
The study volunteers will be invited to take part in the study and will be enrolled only after they 
have agreed to take part by making an informed consent and by signing a consent form. 
 
1.5.1 Inclusion criteria 
A subject will be eligible for study participation if he or she meets the following criteria: 
 
1. Aged 18 years or older (We agreed to study predominantly subjects between 40-75 years 
old, however, I suggest to have age >18 for the protocol to avoid “screening failure” due 
to someone being younger than 40).  
1. Has no history of diabetes 
2. Has no previous history of foot ulceration 
3. Has no previous history of foot surgery 
4. Has palpable foot pulses on both feet (palpable posterior tibial artery or dorsal pedal 
artery or both)  
5. Has no history of peripheral neuropathy 
6. Has no history of peripheral arterial disease  
7. Must be able to provide meaningful written informed consent for the study 
  
1.5.2 Inclusion criteria 
A subject will be excluded from the study if he or she meets the following exclusion criteria 
1. Has active foot ulceration and infection 
2. Has foot deformity which in the opinion of the Investigator, would interfere with 
interpreting the results of the study 
3. Has any uncontrolled illness that, in the opinion of the Investigator, would interfere with 
interpreting the results of the study 
 
 
1.5.3 Selection of participants 
All participants will be recruited over a period of 6 months. A total of 100 participants will be 
recruited between the three clinical centres.  
 
 
1.5.4 Trial procedures 
All subjects will be seen at one visit by the study investigator. The following procedures will be 
performed at the research visit. 
 
1. Obtain written informed consent 
2. Assign a subject number 
3. Review inclusion/ exclusion criteria 
4. Record demographics (age and gender) 
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5. Brief medical history to rule out diabetes, past medical history of foot ulceration/ foot 
surgery, peripheral neuropathy; history of peripheral artery disease 
6. Foot check to ensure that the feet are intact and the person has palpable foot pulses. 
a. Check plantar, dorsal, lateral and medial part of the foot for any lesion; 
b. check for lesions between the toes 
c. palpate pulses at the posterior tibial artery or dorsal pedal artery; if one of the 
pulses is present then the person can be recruited in the study )  
7. Perform skin foot temperature measurements  
 
All subjects should be seen in a temperature controlled room (air-conditioned room set at 21 °C). 
Subjects will be asked to lie down in supine position on a treatment couch and will be asked to 
take off their shoes and socks. They will be asked to rest quietly for 10 minutes to allow 
equilibration of foot temperature.  
 
Skin foot temperatures of the right and left foot will be measured. 
a) Temperature measurement with DFUPS (to follow) 
 
Subjects will be instructed to place their feet in XXXXX position 
Foot protocol measurement: 
 
Sites: ( plantar site, dorsal site, media part of the foot; lateral part of the foot) 
 
 
Position of camera; 
Specifications (light in the room, heating source??? Etc.) 
Image analysis: 
Temperature assessment of regions of interest? 
 
b) Temperature measurement with Dermatemp 1001.  
 
The Dermatemp 1001 thermometer is a non-contact thermometer which measures radiated heat. 
It should be set at the MAX mode and held perpendicular to the scanned area. The reading at the 
display show the maximum temperature of the scanned area (scanned area ≤ size of a 10 pence 
coin). 
The following areas should be scanned and the readings should be recorded in degrees 
Centigrade. : 
 






PLANTAR:    
a. 1
st
 toe    
b. 2
nd
 toe    
c. 3
rd
 toe    
d. 4
th
 toe    
e. 5
th
 toe    
f. 1
st
 metatarsal head    
g. 2
nd
 metatarsal head    
h. 3
rd
 metatarsal head    
i. 4
th
 metatarsal head    
j. 5
th
 metatarsal head    
k. 5
th
 metatarsal base     
l. Heel    
DORSAL     
m. 1
st
 toe    
n. 2
nd
 toe    
o. 3
rd
 toe    
p. 4
th
 toe    
q. 5
th
 toe    
r. 1
st
 metatarsal/ phalangeal joint     
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s. 2
nd
 metatarsal/ phalangeal joint    
t. 3
rd
 metatarsal/ phalangeal joint    
u. 4
th
 metatarsal/ phalangeal joint    
v. 5
th
 metatarsal/ phalangeal joint    
w. 5
th
 metatarsal/ phalangeal joint    
x. 1
st
 metatarsal/ tarsal joint    
y. 2
nd
 metatarsal/ tarsal joint    
z. 3
rd
 metatarsal/ tarsal joint    
aa. 4
th
 metatarsal/ tarsal joint    
bb. 5
th
 metatarsal/ tarsal joint    
MEDIAL    
cc. 1
st
  metatarsal/ phalangeal joint    
dd. 1
st
  metatarsal base    
ee. Medial malleolus (over bony 
prominence) 
   
LATERAL    
ff. 5
th
 metatarsal/ phalangeal joint    
gg. 5
th
 metatarsal base    
hh. Lateral malleolus (over bony 
prominence) 
   
 
The skin foot temperature measurement with the Dermatemp and with the DFUPS will be 
repeated three times as following: 
 
1. DFUPS measurement  
2. Dermatemp 1001 
3. DFUPS measurement  
4. Dermatemp 1001 
5. DFUPS measurement  
6. Dermatemp 1001 
 
 
1.6 Data analysis 
The average of three readings for both Dermatemp and DFUPS will be taken for the purpose of 
the analysis.  
Temperature analysis will include comparisons between corresponding sites between the left and 
the right foot for each instrument and also comparison of temperatures recorded with both 
instruments at the same site.  
Normal variability of foot temperature will be recorded with both instruments.  
A temperature measurement protocol will be developed. 
 
1.7 Expected outcome 
The study will involve skin foot temperature measurements with the proposed prototype and the 
current gold standard thermometry. Although there is no potential benefit for the subjects, these 
measurements will be very important to determine normal ranges and normal variability of foot 
temperature. This study will be fundamental for the subsequent randomised controlled study 
which will be carried out in patients with a previous history of foot ulceration.  
 
                                                     
ii
 Boulton AJM; Diabetic foot – what can we learn from leprosy? 
Legacy of Dr Paul W. Brand; Diabetes Metab Res Rev 2012; 28(Suppl 1): 3–7 
ii
 Lavery LA, Higgins KR, Lanctot DR, et al. Preventing diabetic foot ulcer recurrence in high risk 
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/ /  
Date (dd/mm/yy) 





1. Please ask the Participant to remove shoes and socks and to take a seat on the examination couch 
with legs extended and supported  
 
2. Please switch on the DFUPS device to allow it to reach steady state (remove the flap of the camera) 
 
3. Record TIME AT THE START:  :    (hh:mm);  
 
ROOM TEMPERATURE .  °C ; ROOM HUMIDITY .  % rH 
(Room temperature range - 22°C-24°C) 
DEMOGRAPHIC DATA: 
Initials  Date of Birth: (dd/mm/yy) / /  Sex :  Male   Female 
 Height: .  m    Weight: .  kg BMI .  kg/m2 
 
MEDICAL HISTORY (please insert X to indicate the appropriate answer) Yes No 
1. Have you ever been found to have high blood glucose (e.g. in a health examination, during 
an illness, during pregnancy)? 
  
2. Have you had a previous history of foot ulceration?   
3. Have you ever had a foot surgery either for correction of a previous foot deformity or 
following a foot trauma)? 
  
4. Screening for peripheral neuropathy (Diabetic neuropathy symptom score)    
A. Do you feel unsteady when you walk (unsteadiness in gait)?   
B. Do you experience pain, burning or aching of the feet or legs?   
C. Do you feel prickling sensation of the feet or legs?   
D. Do you have numbness in the feet or legs?   
5. Do you have discomfort in the calf muscle when walking that is relieved with rest?   
6. Do you have any chronic illness which also affects your feet and legs?   
7. Do you have an implantable electronic device   
 
SCREENING FOOT INSPECTION AND EXAMINATION 
CHECK PLANTAR, DORSAL, LATERAL AND MEDIAL PART OF THE FOOT FOR ANY SKIN LESIONS 
CHECK FOR SKIN LESIONS BETWEEN THE TOES 
PALPATE PULSES AT THE POSTERIOR TIBIAL ARTERY AND DORSALIS PEDIS ARTERY  
(if one of the pulses on each foot is present then the person can be recruited in the study) 
 RIGHT FOOT LEFT FOOT 
INTACT FOOT YES  NO  YES  NO  
POSTERIOR TIBIAL PULSE YES  NO  YES  NO  
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Diabetic Foot Ulcer Prevention System (DFUPS): Clinical investigation proforma version 2 (02/3/2015) 
INCLUSION CRITERIA The following criteria MUST be answered YES for participant 
to be included in the trial (except where NA is appropriate): 
Yes No 
1. Aged 18 or over   
2. Answered NO to all questions from medical history    
3. Has intact feet   
4. Has palpable foot pulses   
5. 
Able to fluently speak and understand English and be able to provide meaningful 
written informed consent for the study 
  
 
EXLUSION CRITERIA The following criteria MUST be answered NO for participant to 
be included in the trial (except where NA is appropriate): 
Yes No 
1. Has active foot ulceration and infection   
2. 
Has foot deformity which in the opinion of the Investigator, would interfere with 
interpreting the results of the study 
  
3. 
Has any uncontrolled illness that, in the opinion of the Investigator, would interfere 
with interpreting the results of the study 
  
4. Has an implantable electronic device   
 
REVIEW INCLUSION AND EXCLUSION CRITERIA 
 Yes No 
1. Does the participant satisfy the inclusion and exclusion criteria to date?   
2. Is the participant still willing to proceed in the trial?   
IF YES to 1 and 2 proceed to skin foot temperature measurement protocol 
 
 
Please record the time at the start of the skin foot temperature measurement  
You should allow 10 minutes for the feet of the participant to equilibrate with 
the room temperature  
 :   
(hh : mm) 
 
PATIENT IDENTIFIER FOR DFUPS DEVICE  
 
 /  /  
Centre               Participant       Participant 
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Diabetic Foot Ulcer Prevention System (DFUPS): Clinical investigation proforma version 2 (02/3/2015) 
1. TEMPERATURE MEASUREMENT WITH DFUPS DEVICE AT 10 MINUTES POST SOCKS OFF  
Please insert (X) for each image you have captured 
A. COMBINED PLANTAR VIEW: RIGHT FOOT AND LEFT FOOT  (P1) 
B. COMBINED DORSAL VIEW: RIGHT FOOT AND LEFT FOOT  (D1) 
C. MEDIAL VIEW: RIGHT FOOT  (RM1) LATERAL VIEW RIGHT FOOT  (RL1) 
D. MEDIAL VIEW: LEFT FOOT  (LM1); LATERAL VIEW LEFT FOOT  (LL1) 
 
2. TEMPERATURE MEASUREMENT WITH DFUPS DEVICE AND HAND-HELD THERMOMETER 
PLANTAR SITE PLEASE INSERT (X) FOR EACH IMAGE YOU HAVE CAPTURED  
TEMPERATURE MEASUREMENT WITH DFUPS DEVICE:  
COMBINED PLANTAR VIEW: RIGHT FOOT AND LEFT FOOT  (P2) 
SKIN FOOT TEMPERATURE MEASUREMENT WITH HAND-HELD THERMOMETER  
MEASURE CORRESPONSING SITES INITIALLY ON THE RIGHT FOOT AND THEN ON THE LEFT FOOT. AT THE 
END OF THE SKIN FOOT TEMPERATURE MEASUREMENT CALCULATE THE TEMPERATURE DIFFERENCE (ΔT) 








 TOE (APEX) 
   
2. 2
ND
 TOE (APEX) 
   
3. 3
RD 
 TOE (APEX) 
   
4. 4
TH
 TOE (APEX) 
   
5. 5
TH
 TOE (APEX) 
   
6. 1
ST
 METATARSAL HEAD 
   
7. 2
ND
 METATARSAL HEAD 




   
9. 4
TH
 METATARSAL HEAD 
   
10. 5
TH
 METATARSAL HEAD 
   
11. 5
TH
 METATARSAL BASE  
   
12.  HEEL 
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Diabetic Foot Ulcer Prevention System (DFUPS): Clinical investigation proforma version 2 (02/3/2015) 
DORSAL SITE (PLEASE INSERT (X) FOR EACH IMAGE YOU HAVE CAPTURED) 
SKIN FOOT TEMPERATURE MEASUREMENT WITH DFUPS 
COMBINED DORSAL VIEW: RIGHT FOOT AND LEFT FOOT ; (D2) 
SKIN FOOT TEMPERATURE MEASUREMENT WITH HAND-HELD THERMOMETER 
MEASURE CORRESPONSING SITES INITIALLY ON THE RIGHT FOOT AND THEN ON THE LEFT FOOT. AT THE 
END OF THE SKIN FOOT TEMPERATURE MEASUREMENT CALCULATE THE TEMPERATURE DIFFERENCE (ΔT) 















 TOE (proximal 
interphalangeal joint) 
   
2. 2
ND
 TOE (proximal 
interphalangeal joint) 
   
3. 3
RD
 TOE (proximal 
interphalangeal joint) 
   
4. 4
TH
 TOE (proximal 
interphalangeal joint) 
   
5. 5
TH
 TOE (proximal 
interphalangeal joint) 




PHALANGEAL JOINT  
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Diabetic Foot Ulcer Prevention System (DFUPS): Clinical investigation proforma version 2 (02/3/2015) 
RIGHT FOOT MEDIAL AND LATERAL SITE 
LEFT FOOT MEDIAL AND LATERAL SITE  
(PLEASE INSERT (X) FOR EACH IMAGE YOU HAVE CAPTURED) 
SKIN FOOT TEMPERATURE MEASUREMENT WITH DFUPS 
MEDIAL VIEW: RIGHT FOOT  (RM2) LATERAL VIEW RIGHT FOOT  (RL2) 
MEDIAL VIEW: LEFT FOOT  (LM2); LATERAL VIEW LEFT FOOT  (LL2) 
SKIN FOOT TEMPERATURE MEASUREMENT WITH HAND-HELD THERMOMETER 
MEASURE CORRESPONSING SITES INITIALLY ON THE RIGHT FOOT AND THEN ON THE LEFT FOOT. AT THE 
END OF THE SKIN FOOT TEMPERATURE MEASUREMENT CALCULATE THE TEMPERATURE DIFFERENCE (ΔT) 
MEDIAL SITE 










   
2. 1
ST
  METATARSAL 
BASE 
   
3. MEDIAL MALLEOLUS 
(OVER BONY 
PROMINENCE) 
   
 
SKIN FOOT TEMPERATURE WITH HAND-HELD THERMOMETER 
MEASURE CORRESPONSING SITES INITIALLY ON THE RIGHT FOOT AND THEN ON THE LEFT FOOT. AT THE 
END OF THE SKIN FOOT TEMPERATURE MEASUREMENT CALCULATE THE TEMPERATURE DIFFERENCE (ΔT) 
LATERAL SITE 
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Diabetic Foot Ulcer Prevention System (DFUPS): Clinical investigation proforma version 2 (02/3/2015) 
REPEATED TEMPERATURE MEASUREMENTS WITH DFUPS AND HAND-HELD THERMOMETER – 
(PLANTAR SITE ONL) 
PLANTAR SITE DFUPS DEVICE: COMBINED PLANTAR VIEW RIGHT AND LEFT FOOT ; (P3) 








REGION OF INTEREST:  RIGHT FOOT °(C) LEFT FOOT °(C)  (ΔT) 
1. 1
ST
 TOE (APEX) 
   
2. 4
TH
 TOE (APEX) 
   
3. 1
ST
 METATARSAL HEAD 




   
5. 5
TH
 METATARSAL HEAD 
   
DFUPS DEVICE: COMBINED PLANTAR VIEW RIGHT AND LEFT FOOT ;(P4)  
SKIN FOOT TEMPERATURE WITH HAND-HELD THERMOMETER 
REGION OF INTEREST:  RIGHT FOOT °(C) LEFT FOOT °(C)  (ΔT) 
1. 1
ST
 TOE (APEX) 
   
2. 4
TH
 TOE (APEX) 
   
3. 1
ST
 METATARSAL HEAD 




   
5. 5
TH
 METATARSAL HEAD 
   
DFUPS DEVICE: COMBINED PLANTAR VIEW RIGHT AND LEFT FOOT ; (P5) 
SKIN FOOT TEMPERATURE WITH HAND-HELD THERMOMETER 
REGION OF INTEREST:  RIGHT FOOT °(C) LEFT FOOT °(C)  (ΔT) 
1. 1
ST
 TOE (APEX) 
   
2. 4
TH
 TOE (APEX) 
   
3. 1
ST
 METATARSAL HEAD 




   
5. 5
TH
 METATARSAL HEAD 
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Diabetic Foot Ulcer Prevention System (DFUPS): Clinical investigation proforma version 2 (02/3/2015) 
 





CHECK PLANTAR, DORSAL, LATERAL AND MEDIAL PART OF THE RIGHT AND LEFT FOOT FOR ANY 
DEVICE-RELATED ADVERSE EVENTS   
 Yes No 
1. 
Have there been any DEVICE-RELATED Adverse Events (AE)? 





DEVICE-RELATED Adverse Events EVENTS LOG  
 
AE No 
Event Name  

















IN THE RARE CASE OF AN ADVERSE EVENT, PLEASE REFER THE PATIENT FOR AN 
ASSESSMENT BY THE MEDICAL TEAM AND TREAT ACCORDINGLY.   
 
PLEASE REPORT ANY DEVICE-RELATED ADVERSE EVENTS TO THE CLINICAL SPONSOR OF 
THE STUDY  
 
 
END OF STUDY PROTOCOL  
THANK THE PARTICIPANT; DON’T FORGET TO CHARGE THE BATTERY FOR DFUPS DEVICE;  
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1. Background & Rationale 
The global burden of diabetes is well recognised. At present, it is estimated that 382 million 
people have diabetes and by 2035 it is predicted that diabetes will affect 592 million people 
(http://www.idf.org/diabetesatlas/introduction). Almost 50% of the people with diabetes 
develop neuropathy (nerve damage to the feet). The latter is characterised by a lack of pain 
and protective sensation to the feet of people with diabetes and increases the risk of foot 
ulceration, infection and even amputation. The lifetime risk of a patient with diabetes to 
develop foot ulcer is between 15 and 25% (1). Foot ulceration seriously affects the patient’s 
quality of life and is associated with increased mortality (2, 3, 4).  
 
Foot ulceration is the commonest reason for people with diabetes to be admitted to hospital. It 
is currently estimated that about £10 billion is spent by the NHS on diabetes and diabetic foot 
disease accounts for a significant amount of these resources. Furthermore, up to 70% of 
patients with a history of foot ulcers experience recurrence within 1 year (5, 6, 7). Early 
recognition and management of foot ulceration is critical to avoid adverse outcomes, as it is 
now well accepted that “TIME IS TISSUE”. Thus, prevention of foot ulcers is of paramount 
importance and its priority is well recognised by the International Working Group on the 
Diabetic Foot (IWGDF), (8). 
 
Timely identification of patients is fundamental in the prevention of diabetic foot ulceration. 
Recently, infrared thermography has attracted a lot of attention as a possible useful modality 
for early detection of incipient tissue damage in high-risk patients (9). The importance of foot 
skin temperature monitoring to identify the early signs of inflammation has been emphasised 
in the 2015 guidelines of the IWGDF, as it may facilitate the early recognition of patients at 
risk (8).  
 
There is now a variety of instruments evaluated in the examination of the diabetic foot (9, 10, 
11), but neither of these has become widely available. At present, mainly single spot hand-
held thermometers are used in clinical practice, which measure temperature only above the 
scanned area and do not provide information of the surrounding area (9). Furthermore, an 
incipient lesion may also be characterised by a rise of skin foot temperature but is not 
obviously visible on clinical examination. Therefore, a thermal image of the feet will allow 
full examination and early detection of areas at risk. Indeed, the potential of thermal map 
imaging (thermography) to assess diabetic foot disorders has been recently emphasised (12). 
 
Recently, in collaboration with scientists from the National Physical Laboratory, Photometrix 
Imaging Ltd and the University of South Wales, we have developed a new non-invasive 
infrared thermal camera called Diabetic Foot Ulcer Prevention System (DFUPS). This 
camera captures at the same time a visual image and a thermal image. The performance of 
this imaging camera has been evaluated under laboratory conditions at the National Physical 
Laboratory.  
 
In addition, we carried out a multi-centre clinical trial and assessed the usefulness of DFUPS 
device to measure the temperature distribution in the feet of healthy participants. We 
demonstrated the efficacy and safety of DFUPS device to detect temperature distribution 
(thermal map imaging) in normal feet. Taking thermal images with DFUPS is fast, non-
invasive and reproducible. This technique allows spatial mapping of the foot in a single 
image. We developed a protocol to assess with DFUPS all sites of each foot (plantar, dorsal, 
medial and lateral).  In addition to a temperature map of each foot, this technique allows the 
comparisons of corresponding areas of interest between feet. This principle is widely 
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accepted in the assessment of the diabetic foot to identify areas at risk of ulceration. The 
images captured with DFUPS allowed visual and thermal assessment of all sites of the feet 
and also between corresponding sites. Thus DFUPS device holds the potential to become a 
real asset in the diabetic foot clinic, fulfilling the requirements of “an ideal device being user 
friendly, reproducible and accurate” (9). We now plan to translate the skin foot temperature 
measurement protocol with DFUPS into clinical practice and use it in the assessment of 
diabetic patients at risk of foot ulceration. We plan to measure with DFUPS the temperature 
distribution in the feet of diabetic patients with past history of one or more foot ulcerations.  
In addition, we plan to follow up these patients with or without thermography to assess the 
ulcer recurrence rate.  
 
We hypothesise that monitoring patients with DFUPS together with standard foot care will be 
more effective compared with standard foot care alone as it will identify incipient tissue 
damage in patients at high risk for diabetic foot ulceration thus reducing the incidence of foot 
complications. In particular, we hypothesise that the ulcer recurrence rate will be significantly 
lower in the active group (thermography plus standard foot care) compared with standard foot 
care alone.  
 
If we demonstrate the efficacy and safety of DFUPS to reduce the incidence of foot 
ulceration in diabetic patients at high risk, we plan to carry out a further phase III efficacy 
trial to assess the usefulness of this instrument in ulcer prevention. The overall aim is to 
translate this technique to everyday routine clinical practice so that DFUPS is not only an 
instrument used at annual diabetes review but also an instrument available in every podiatry 
practice for routine monitoring of high risk patients. We believe that this technique, if 
available and accessible to clinical centres, could become a useful tool to prevent diabetic 
foot ulceration and significantly reduce ulcer reoccurrence.  
 
2. Trial Device, Objectives and Design  
A. Description of the Device: 
 
The DFUPS device is a two-camera instrument for capturing images of feet. One of the 
cameras is a standard digital colour camera that works with visible light. The other camera is 
an infrared camera that registers the heat emissions from objects and converts these into an 
image from which temperature measurements can be made (thermogram). We will request an 
MHRA approval to use this device in the proposed clinical trial.  
B. Trial Objectives 
 
1. Primary objectives 
 To assess the performance of DFUPS in detecting areas of impending tissue 
breakdown in high-risk patients with diabetes and past history of foot ulceration. 
 To assess the safety of thermal imaging using DFUPS in a clinical setting  
 
Primary measures will be collected at baseline and then monthly with a final visit at month 
12. The primary endpoint with respect to effectiveness of DFUPS in reducing the incidence 
of diabetic foot ulcers will be the proportion of patients in each group developing a foot ulcer 
of any type. Ulceration will be defined as the full thickness loss of epidermis and dermis or 
involvement of deeper structures below the malleoli.  
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The safety of DFUPS will be assessed and any device-related adverse events will be 
recorded. 
 
2. Secondary  objectives  
 Time to ulceration   
 Health related quality of life (EQ-5D-5L) 
 Number of visits to the foot clinic (study visits and clinical visits) 
 DFUPS usability feedback from patients and from health care professionals 
  Post treatment evaluation at 12 months 
 Total number of ulcers per patient developed over the last 12 months  
 Total number of hospital admissions as a result of a foot ulceration over the 
last 12 months 
 Total duration of hospital admissions over the last 12 months 
 Number of amputations over the last 12 months 
 Number of deaths 
 
C. Trial Design 
 
This is a multi-centre single blinded randomised clinical trial in people with diabetes. Patients 
should have either type 1 or type 2 diabetes and a past history of foot ulcer which has been 
healed for at least 3 months. 
 
Patients will be recruited consecutively and asked whether they would like to take part in the 
study. They will be provided with verbal and written explanation of the study aims and 
details (Patient Information Sheet). Subjects will be given ample time to decide whether or 
not they wish to take part in the study. Patients will be enrolled in the study only after they 
have agreed to take part. Patients should express their willingness to take part in the study by 
signing a consent form.  
 
Patients will be seen at an initial visit to assess their suitability to take part in the study. Initial 
investigations at this visit will consist of brief medical history, foot assessment (inspection, 
palpation of pulses and assessment of neuropathy), thermal image with DFUPS and review of 
the inclusion/ exclusion criteria. 
 
Patients who fulfil the study criteria and are willing to take part in the study will be 
randomised at this visit and then monitored monthly in the clinic and assessed with DFUPS at 
each study visit. The device will be set up in the visual mode and visual images of all sites of 
both feet will be obtained at each visit. All patients will receive foot care as per local 
standards of care. Patients will be randomised in a 1:1 ratio into the following groups:  
 
Group A: Intervention group: Visual and thermal imaging with DFUPS and standard foot 
care. The study investigator will have access to the thermal and visual images captured with 
DFUPS. 
 
Group B: Placebo group: Visual and blinded thermal imaging with DFUPS and standard foot 
care. The study investigator will have access only to the visual images and will be blinded to 
the thermal images which will be captured at each visit but accessed only at the end of the 
study.  
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It is expected that thermal imaging with DFUPS in the active group will be able to detect a 
hot spot area (an early fore-runner of foot ulcer) which may not be readily detected by a 
routine podiatric assessment. We hypothesise that if these hot spots are detected early and 
monitored until they resolve, the intervention with thermal imaging will reduce the risk of 
ulcer recurrence in group A.  
 
Patients will be allocated to treatment groups using randomisation numbers obtained from the 
study statistician at King’s College Hospital NHS Foundation Trust. 
 
All patients will receive podiatric treatment which includes callus debridement and pressure 
offloading (general therapeutic offloading with footwear/ insoles) as per local standards of 
care. Patients will be followed monthly for routine foot care. Between the follow up visits, 
the visit window will be ±7 days. 
 
In addition patients, allocated to group A, will be monitored monthly with thermal imaging 
using DFUPS. All sites of the foot will be assessed for the presence of hot spots. A hot spot 
will be defined as an area with a temperature difference between corresponding sites equal to 
or greater than 2.2°C, (7, 11). If a hot spot is detected, the patient will be informed and asked 
to reduce his/her daily activity and will be reassessed within 2 weeks with DFUPS (visual 
and thermal imaging). If the hot spot is still present, the area will be monitored/protected as 
per local standards of care and the patient will be followed up every 2 weeks until the hot 
spot resolves. Resolution of the hot spot will be defined as a temperature difference between 
corresponding sites less than 2.2°C (7, 11).  
 
Patients will be followed monthly for routine foot care and imaging assessment with DFUPS. 
The following tests will be performed: 
 
• Foot inspection to rule out foot ulceration at presentation and ulcer recurrence on 
follow up. 
• Imaging assessment with DFUPS. The device captures at the same time a visual and a 
thermal image (thermogram). For the study, the device will be set up to display only 
the visual image. Plantar, dorsal, medial and lateral views of each foot will be taken. 
During the study, the investigator will have access to the visual images for all subjects 
(Group A and Group B) and to the thermal images only for subjects allocated to 
Group A.  
At each visit, the thermal images in group A will be assessed for the presence of hot 
spots. Although Group B will be also imaged with thermography, both the patient and 
the study investigator will be blinded to the captured thermal images at each visit. The 
study investigator will be able to access the thermal images only when the subject has 
completed the study  
 Safety evaluation. At each study visit, we will record any device related adverse 
events. 
 
D. Trial flowchart 
 







FINAL STUDY VISIT 
(Last treatment visit and/ or 
post treatment evaluation) 
Visit Number 1 2 3 4 5 6 7 8 9 10 11 12 13 
Month 0 1 2 3 4 5 6 7 8 9 10 11 12 
Patient information and 
informed consent 
X             
Medical history and 
demographics 
X             
Foot inspection to rule out 
any lesion 
X X X X X X X X X X X X X 
Palpation of pulses to rule 
out peripheral arterial 
disease 
X             
Neuropathy assessment 
 
X             
Assessment with DFUPS 
(visual mode) 
X X X X X X X X X X X X X 
EQ-5D-5L X   X   X   X   X 


























Post-treatment evaluation             X 
*Group A only – assess thermal images and if according to the investigator there is an evidence of hot spot advise the patient accordingly 
and assess at an intermediate study visit at 2 weeks 
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3. Selection and Withdrawal of Participants 
A. Inclusion Criteria 
A subject will be eligible for study participation if he or she meets the following criteria: 
 
• Aged 18 years or older   
• Has either type 1 or type 2 diabetes 
• Has intact feet as defined by the absence of a skin breakdown below the malleoli.  
• Has neuropathy confirmed by impaired sensation to neurothesiometer (vibration 
perception threshold > 25 volts on one OR both feet) 
• Has a past history of ≥1 foot ulceration (s) which has (have) resolved in the last 3 
months  
• Has palpable foot pulses on both feet (palpable posterior tibial artery pulse OR 
dorsalis pedis artery pulse OR both)  
• Has no history of peripheral arterial disease  
• Has footwear which in the opinion of the investigator is not likely to cause pressure 
damage  
• Must be able to provide meaningful written informed consent for the study 
 
B. Exclusion Criteria 
A subject will be excluded from the study if he or she meets the following exclusion criteria 
• Is aged <18 
• Has foot deformity that in the opinion of the investigator would interfere with the 
interpreting of the results of the study. 
• Has previous history of foot surgery which in the opinion of the study investigator 
could interfere with the interpreting the results of the study 
• Has active foot ulceration and infection 
• Has active Charcot osteoarthropathy 
• Has established Charcot foot deformity that in the opinion of the study investigator 
would interfere with the interpreting of the results of the study. 
• Has any uncontrolled illness that, in the opinion of the study investigator, would 
interfere with interpreting the results of the study 
• Has an implantable electronic device 
 
C. Selection of Participants:  
People with diabetes will be recruited at 3 clinical sites:  
 
• Diabetic Foot Clinic, Kings College Hospital NHS Foundation Trust, London 
• Podiatry Department, Centre for Aging and Vitality; Newcastle upon Tyne Hospitals 
NHS Trust, Newcastle upon Tyne  
• Community Podiatry Department and North Manchester General Hospital Diabetes 
Centre, Pennine Acute Hospitals Trust, Manchester. 
 
Patients will be treated and followed up in the recruiting centre. We plan to randomise 100 
patients between the 3 centres and follow them up until a recurrence of a foot ulcer or up to a 
period of 12 months (whichever comes first). The expected maximum number of visits/ 
subject will be 13 visits over 12 months. These will include an initial visit (screening/ 
randomisation) and 12 follow up monthly treatment visits (group A and B).   
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In addition, if the thermogram at the initial visit or at any one of the follow up treatment visits 
indicates a hot spot, the subjects randomised in group A will be advised to reduce their 
physical activity and will be seen at a 2-weekly intervals to assess the resolution of the hot 
spot.  Thus in the rare event of a persistent hot spot during the whole study, the maximum 
number of visits for subjects randomised in group A will be 25 visits over 12 months. We 
anticipate that patients should attend at least 75% of the follow up treatment visits (Group A 
and Group B).     
 
If a subject develops a foot ulcer at any one of the follow up monthly treatment visits, this 
will be their last treatment visit. These patients will be asked to attend a post treatment 
evaluation at 12 months. If the patient cannot attend the post treatment evaluation at 12 
months for whatever reason, at the last treatment visit we will ask the patient’s permission to 
contact him/her by phone at 12 months as part of a telephone assessment.  
 
D. Randomisation Procedure 
Patients will be randomised in a 1:1 ratio to assessment with visual and thermal imaging with  
DFUPS and standard foot care (Group A) or to assessment with visual imaging and blinded 
thermal imaging with DFUPS and standard foot care (Group B) using simple randomisation 
based on computer generated list. All subjects will be assessed with visual imaging with 
DFUPS. Thermal images will be only accessible during the study for subjects randomised in 
group A. Thermal images for subjects randomised in group B will be accessible by the study 
investigator only after the subject has completed the study. The study participants will be 
blinded to the group allocation.  
E. Subject Withdrawal 
Subjects will be withdrawn if: 
 They develop an acute active Charcot foot 
 They sustain a foot or ankle fracture 
 They develop any condition which in the opinion of the investigator would interfere 
with interpreting the results of the study 
 They are not compliant (it is expected that the study participants should attend at least 
75% of the follow up treatment visits (≥9 follow up treatment visits) 
 
In addition subjects are free to withdraw at any time without giving a reason. Patients who 
develop adverse events which necessitate withdrawal from the study will be followed up in 
the recruiting Foot Clinic at each investigation site.  
If a subjects withdraws from the study for any reason, we will use all the data collected up to 
withdrawal, provided the subject consents to this by signing the informed consent form.  
If a subject is withdrawn from the trial as a result of a (serious) adverse event, the subject will 
be followed-up until the event resolves or stabilises. 
 
F. Subject Compliance 
The number of attended research visits will be recorded. Subject compliance will be 
determined monthly. We anticipate that each patient should attend at least 75% of the follow 
up treatment visits.    
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G. Expected Duration of Trial 
The study is planned for 18 months. Recruitment will take place over 4 months. We plan to 
randomise a total of 100 patients between 3 clinical centres and follow them up for a period 
of 12 months. Last patient last visit will define the end of the trial at each site. 
 
4. Trial Procedures 
At each centre, all trial procedures will be carried out by delegated and trained members of 
the research team. 
 
Subjects will be initially seen at an initial visit for screening and randomisation (if eligible) 
and then will be monitored monthly for 12 months (12 follow up treatment visits). At the last 
treatment visit at 12 months we will also carry out a post-treatment evaluation. This will be 
the study final visit. If a patient develops and ulcer at any one of the follow up visits, this visit 
will be the last treatment visit for this patient (early termination) and at 12 months, this 
patient will be invited to attend the final study visit for a post-treatment evaluation.   
Initially, the patients will be asked to take off their shoes and socks and then to sit on a 
treatment couch with legs extended and supported. They will be asked to rest quietly for 10 
minutes to allow equilibration of their foot temperature with the room temperature (22-24°C). 
Room temperature and humidity will be measured at the beginning and at the end of each 
foot assessment using a calibrated room temperature sensor (HygroPalm, Rotronic).  
 
The following tests will be performed: 
 
1. Imaging with DFUPS.  
 
All sites of the right and left foot (plantar, dorsal, medial and lateral) will be imaged with 
DFUPS. The camera will be set up on the visual mode according to instrument requirements 
detailed in the instructions for use of medical device. A baseline imaging sequence (10 
minutes post sock-off) will be captured. The imaging sequence will be repeated after 10 
minutes (20 minutes post socks-off).  If the patient has hard skin (callus); the imaging 
sequence will be repeated 10 minutes post callus removal.  
Thermal images will be assessed only in subjects randomised in Group A. If the thermal 
image shows a hot spot on both sequences (baseline and repeated imaging sequence), which 
in the opinion of the investigator is indicative of incipient tissue damage, the patient will be 
advised to reduce their daily physical activity and assessed in 2 weeks.  
 
2. Self-administered  EQ-5D-5L questionnaire   
 
Patients’ quality of life will be assessed using EuroQol questionnaire. We plan to useEQ-5D-
5L. Applicable to a wide range of health conditions and treatments, this questionnaire 
provides a simple descriptive profile and a single index value for health status. It will be 
administered at the initial visit and then at 3 monthly intervals. If at any of the follow up 
treatment visits the patient presents with a new ulcer (ulcer recurrence), EQ-5D-5L will be 
administered at this visit (early withdrawal visit) and then at the final study visit at 12 
months. The rate of change in the mean difference of EQ-5D-5L scores from baseline and up 
to the final visit will be assessed.  
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3. Patient satisfaction/ experience questionnaire.  
 
Patients will be asked to complete a short experience questionnaire about DFUPS at 
screening.  
 
4. Number of foot clinic appointments since their previous study visit will be 
recorded.  
 
Patients will be asked for any foot clinic appointments that they may have had since their 
previous study visit. 
 
5. Post treatment evaluation at 12 months 
 
This will be carried out at the final study visit (defined either as the last treatment visit if the 
patient has not developed an ulcer or as a post treatment evaluation if the patient has 
developed an ulcer at any one of the treatment follow up visits). For the latter, the post 
treatment evaluation will be carried out either in the clinic or as part of a telephone 
assessment and/or assessment of electronic patient records. We will record data on: 
 
a. total number of ulcers that the patient has developed since randomisation  
b. total number of hospital admissions required for treating diabetic foot ulcer 
over the last 12 months 
c. total duration of hospital admissions  over the last 12 months 
d. number of amputations required for the treatment of diabetic foot ulcer 
over the last 12 months 
e. number of deaths  
 
A. Trial procedures by visit 
Initial visit (Screening/ Randomisation Visit) 
The following procedures will be performed. 
 
A. Screening:  
1. Obtain written informed consent 
2. Assign a subject number 
3. Record medical history and demographics  
4. Foot check to ensure that the feet are intact and the patient has palpable foot pulses. 
a. Check plantar, dorsal, lateral and medial part of each foot for any lesion; 
b. Check for lesions between the toes 
c. Palpate pulses at the posterior tibial artery and dorsalis pedis artery; if one of 
the pulses is present then the patient can be recruited in the study  
d. Determine presence of neuropathy, confirmed by impaired sensation to 
neurothesiometer (vibration perception threshold≥25 volts on one or both feet) 
Vibration perception threshold in volts will be measured at the apex of the 
hallux and will be determined as an average of three readings as previously 
described (13); Vibration perception threshold > 50 V will be taken as 50 V 
for the purpose of the analysis.  
5. Assess current footwear and encourage the patient to wear properly fitted shoes  
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6. Image both feet with DFUPS. The camera will be set up on the visual mode; all sites 
of both feet will be imaged (plantar, dorsal, medial and lateral sites). 
7. Assess for any device related adverse events 
8. Administer DFUPS satisfaction/experience questionnaire 
9. Review inclusion/ exclusion criteria  
a. If the patient fulfils the study entry criteria and is still willing to take part in 
the study, please proceed to randomisation  
b. There will be no further study visits for subjects who do not fulfil the 
inclusion/ exclusion criteria.  
 
B. Randomisation - all patients who fulfil study entry criteria will be randomised 
at this initial visit. The following procedures will be performed: 
 
1. Assign a randomisation number if the patient is eligible to take part in the study. 
2. Repeat imaging with DFUPS.  The camera will be set up on the visual mode; all 
sites of both feet will be assessed (plantar, dorsal, medial and lateral sites). 
3. Administer EQ-5D- 5L 
4. Check group allocation 
5. If the subject is randomised to group A, assess thermal images of both feet for any 
hot spots and advise accordingly.  
6. Assess for any device-related adverse events 
 
Treatment visits (visit 2 (month 1); visit 3 (month 2) etc. 
The following procedures will be performed at each follow up monthly treatment visit. 
 
1. Carry out routine podiatric assessment and treatment (foot inspection for any skin 
breakdown, callus removal and general foot assessment) 
2. Administer EQ-5D- 5L at 3-monthly intervals (months 3, 6, 9 and 12); (visit 
4,7,10 and 13). 
3. Capture images with DFUPS 
4. Assess for any device-related adverse events 
5. If the subject is randomised to group A, assess thermal images of both feet for any 
hot spots and advise accordingly.  
 
 
Post treatment evaluation 
The post treatment evaluation will take place at month 12. This will be carried out during the 
last treatment visit for subjects from Groups A and B who have not developed an ulcer. 
Patients who have developed an ulcer from Groups A or B at any one of the follow up visits 
(early termination visit) will be invited for an assessment to the clinic at 12 months. If the 
patient is not willing to attend this appointment we will ask their permission to carry out a 
telephone assessment and to review the electronic patient’s records. 
At this post treatment evaluation we will record data on: 
 Total number of ulcers per patient developed over the last 12 months  
 Total number of hospital admissions as a result of a foot ulceration over the 
last 12 months 
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 Total duration of hospital admissions over the last 12 months 
 Number of amputations over the last 12 months 
 Number of deaths 
 
Early termination visit 
Early termination visit may take place at any time if the patient decides to withdraw; or the 
patient develops an ulcer/ ulcers below the malleoli on either foot.  
If the patient develops an ulcer at any one of the treatment visits, this will be their last 
treatment visit. These patients will be invited to attend a final study visit at 12 months or if 
unwilling to attend the clinic, the patients will be asked to take part in a post-treatment 
evaluation by telephone. We will also ask for their permission to access their electronic 
patients’ records. 
5. Assessment of Efficacy 
A. Primary efficacy parameters 
 
The primary objective is to determine whether thermography with DFUPS together with 
standard foot care can reduce the incidence of ulcer recurrence in diabetic patients at high 
risk of foot ulceration. We aim to determine whether there is a difference between the 
proportions of patients in each group developing a foot ulcer of any type. 
We will compare the groups with regards to: 
Device Efficacy, assessed as percentage of patients with recurrent foot ulcer  
Device Safety, assessed as device-related adverse events 
 
B. Secondary efficacy parameters 
 
The secondary objectives will be to determine whether there is a difference between the two 
groups with regard to: 
 Time to ulceration 
 Rate of change of score in quality of life from baseline and up to the final visit using 
the EQ-5D-5L  
 Total number of visits to the foot clinic (study visits and clinical visits) 
In addition at 12 months, we will carry out a post treatment evaluation and we will assess 
any differences between the groups with regards to:  
 Total number of ulcers developed over the last 12 months  
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 Total number of hospital admissions as a result of foot ulceration over the last 12 
months  
 Total duration of hospital admissions over the last 12 months  
 Number of amputations 
 Number of deaths 
 
6. Procedures for Recording and Reporting Adverse Events 
At each visit subjects will be assessed for any device related adverse events which will be 
reported in timely manner to Medicines and Healthcare products Regulatory Agency 
(MHRA).  
7. Statistics 
A. Sample Size: 
 
We will recruit an effective sample size of 100 patients to be randomised to the two groups 
(Placebo is the standard care group and Intervention is the thermography monitored group). 
Recurrence of ulceration within one year has been found to be 70% in the placebo group and 
between 30% and 45% in the intervention group (7). An effective sample size of 50 patients 
in each group will provide 80% power, at the 5% significance level, to detect groups 
differences of: an odds ratio of 0.29 (70% vs 40% in terms of the percentage of recurrences), 
an intervention vs placebo hazard ratio of 0.5 (in terms of recurrence and survival times) and 
an effect of size 0.58 in terms of the difference in the change in the quality of life score from 
baseline.  
We aim to recruit 112 patients in total among the 3 centres (average 37 patients per centre) to 
allow 10% drop-out rate. 
 
B. Randomisation 
Randomisation will be carried out in the Diabetic Foot Clinic at King’s College Hospital by 
the study statistician using simple randomisation based on computer generated list. 
C. Data Analysis 
This is a randomised controlled trial. The primary outcomes for treatment efficacy are: a 
binary indicator for ulcer recurrence after 1 year follow up and the time to ulcer recurrence. 
The secondary outcome for efficacy is the change in quality of life from baseline as measured 
by the EQ-5D-5L instrument. Primary measures will be collected at baseline and every 3 
months thereafter (months 0, 3, 6, 9 and 12), with a final visit at month 12 and safety will be 
monitored in terms of the rate of adverse events as defined in the protocol. Interim analyses 
(stopping rules) on the primary and secondary outcomes will not be performed. 
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We will use logistic regression to model the likelihood of ulcer recurrence within one year 
and a Cox’s regression to model the time-to-ulcer-recurrence patterns in the control and 
experimental groups. Linear regression will be used to model the changes in quality of life 
scores from baseline. 
 
8. Data Handling 
Personal data will be stored on password protected NHS hospital computers and each 
principal investigator will act as custodian for the trial data at each site.  Paper files will be 
kept in locked safety cabinets at each participating centre. 
All patients’ data will be anonymised. Only anonymised data will be sent across sites and 
used for the analysis.  
9. Publication Policy 
It is intended that the results of the study will be reported and disseminated at international 
conferences and in peer-reviewed scientific journals. 
10. Funding Aspect 
Funding to conduct the trial is provided by the National Institute of Health Research (NIHR). 
The grant holder is the National Physical Laboratory. King’s College Hospital NHS 
Foundation Trust is the clinical sponsor of this study.  
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Figure F.2: Website instructions (part 2)
Figure F.3: Website instructions (part 3)
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Figure F.4: Website instructions (part 4)
Figure F.5: Website instructions (part 5)
Figure F.6: Toolbox and working area
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